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INTRODUCTION 
The impariance ot fa\v acids as an energy producing substrate in 
iey-ocardial me1iabolism ha.a been confirmed in many reports utilizing both the 
isolated and in\aot heart preparations. Fatty acids are transpor1H'd to the 
heart via 'the afterial blood in aaaocia'ii.on With albumin and account for 
60-65% ot the total cardiac metabolism. In these reporu, it was suggested 
that the fa'"7 acid upt.ake b7 the hear\ aa indireotlT controlled primarily 
through changes in the &Meri.al blood oonoenn ti. on entering the 1qocardium. 
Other factora al.so reported '\o indirectly attae\ fatty acid uptake includes 
1) album.tn-tatt7 acid molar ratio, 2) tatty acid chain lengih and satura\ion, 
3) COroJ'l&?'7 blood now and 4) rate of in'1'aoellular oxidation. The 
inaporlance at '\hue f acton in the &l!, !ill heart has no\ been clarified. 
Mere reoen'\ nidenoe baa augges\ed that '\he man -.y directly regula'M tatv 
acid up1iake through al\erationa in a)'llp&thatic nerve activi\7. 
Early repans dealing wi:tih the etteds ot catecholudnes on iqooardial. 
metabolism haw damons'Ua tad a reduction in the cardiac respiratory quotient 
following the adminia1-ra\ion or epinephrine in the isolated h.ean. In more 
recent studies, s'tiiml.ation ot l\Yocardial f'a'\t7 acid uptake and oxidation, 
subsequent to catecholamine &dminis'\ration, has been confi:naed Jin nm and 
in vivo. These reports have attributed the increase in fatty acid uptake to 
l 
2 
the elevated energy requirements of the heart produced by the sympa\hetic 
amines as well as the increase in ar\erial fatty acid conoen\:ration. This 
would sug?,'est a regulatory mechanism wh:tch is indirectly dependent on in'tra-
cellular oxidation prcportional to increased cardiac work and &r'Mtrial level• 
ot tatty aeida. However, the possibility '\ha\ ca'tlecholami:oos mllY" have a 
direct etf ee\ on cardiao lipid metabollam. •s supported by' studies in 'the 
isola'\ed arrea'Md haan. In this :preparation, no ex\ernal work was performed 
and arkrlal lewls wre held ccms'ian~ )"9t <>2 comumption inoreued during 
epinephrine intuaion which was related 'o stimula'lion of tatty acid uptake 
and oxidation. 
'Ii th the in,roduction ot bnh ~- and 19-reoep•or blocking drugs, 1fhe 
imponanoe ot \he 8111Pfl\hetio nervows s;rnem in eontrolling metabolic 
reactions •• be\ter olaritied. This was exemplitied in studies dealing with 
the comrol ot ta\'Q' acid release from adipose ti.ssue. I\ waa found tha'ti P-
recep'\or agoni•ts atiJnula'ed tatv acid releaa•• whereas it-receptor an'\ago-
nia\a as wll u sympathetic denenation prnented their release. '.l'he 
•chanism ot •hese reaetions •• related to ad81\Yl cyclase activ11ty. 
Eleva1iions in qclic 3' 1S' adenosine monophoephatie in the cell resul:\s in 
\he activa\ion ot a "bermone-eens1t1Te" lipase Which atimlatea the degra-
da1iion ot endoeenou 1rig110eridea. Thia oauna an elArta'\ion ot intraoellular 
tat'\y acid levels which are paaaivel.T transported in'\o the blood, resulting 
in an elevati.on ot arterial co:neenvations. Adllinis1iration or P,.recep'tior 
blocking drugs inhibit;s basal and catecholamine-stimulat.ed lipol,ysis ot. 
aciipose ·tissue coneomi tant With an increase in triglyceride levels by 
possibly inhibiting ade:qyl cyclase. 
The substrates and enzymes present in adi!'ose tissue eoncerned w.l th ta\ty 
acid release are ~imilar to those fourd in cardiac muscle. This would augges1; 
tha't a similar mechanism llaJ" be involved in the transport of ta:\ty acids into 
1ihe cardiac mul!cle cell. The increase in f'atty acid up\ake and axidatton 
found with sympathetic amines is also supported by the recent report that tri-
g:cyceride leTEJls increase in cardiac muscle trea.ted With 13-blocldng compounds. 
It was the :purpose ot this disser\ation to explore the mechanisms 
involved in fa\1;y aeid 'transporl into the oa:rdiac cell concomitant with sub-
cellular chang•• in lipid components wi\h emphasis on the role of the sympa-
thetic nervous aysiiem and the ~drenergic receptor. Since the impor'iance of 
these mechanl.sms is intimately related to the role they pl.ay in maintaining 
the tunc1iional integriv ot '\he ii,~ hear'\, the in1.tial experiments were 
pertormed in tile open-chest dog bstore an;y a'"ertpt was made to EmLluate 
subcellular charges. In 'bheae studies, Jqocardial carbohydraw arxl tatty 
acid subetrat.es wre measured by a~ing 'be anerio-venous difference. 
The results ot "heae s\,ldi.es indica'Ud a relationship between lipid ae~boliam 
and IJ-reoep\or actirlty- in the in %1!9. hean. To further clarity \his 
relationship, aubcellular f'ree tatty- acids, '\r:!glyoeridee and phospholipids 
were measured during al'\lerations in ,_reoep•or activ.tv. These studies 
suggest a possible mechanism for fatty acid uptake by the heart regulated 
by the sympathetic nervous system. 
CHAPTm l 
REVIEW OF' THE LITEP.ATURE 
A.. EARLY LITERATURE 
Modifications of the i:Jolated heart techniq,ne of Langendorfr (1895) 
provided earq investigators With a.n ideal preparation for the sttdy ot 
cardiac metabolism. Prior to 1914, interest in aubs1orate t1ptake by 1ihe 
heart was oen\ered primarily on carboh;rdra,es (Locke am R08enheim, 19'Yl and 
Know:Lton and S'8.rl1ng, 1912). lfeuuremellU ot glucose uptake coupled with 
respiratory quotients (R.Q.) provided mos'\ ot the evidence tor energy 
production in the heart. However 1 Evans (1914a) sugges\ed ~t. onl.1' 1/3 ot 
the energy production ot the hean was sa'istied by earbolzydra'\e cxx:idation. 
He found that isolated hearts trom dogs maintained on a diet c"na1sting largelJ 
ot butter had very low R. Q. •s. Cruickshnnk (1936) r13ported an average R. Q. 
ot 0.699 in '\he aglycem.1..c rat hea.rl. He stated 1lha1i "when a heart main'\ains 
a rate ot 160 beats per minute, a blocd pressure ot 90-100 mm/Hg tor three 
hours with not a trace ot blood sugar and an R. Q. Tarying between 0.72 am 
o.68 wi.th an average over five J()...nd.nute periods of o.699, then there is no 
question ot the ability of the isolated heart muscle to utilize tat." 
These early investigators were limited to the study of glucose and 
lae\ate uptake due to the long, laborous and error ridden methods tor 
de1'erm.inig fat (Bloor, 19261 Stoddard and Drury, 1929 ard Man and Gildea, 
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1932). However, using the Bloor method, Visscher (1938) found that ta\ 
content of the noIH7orking dog heart was higher than that or world.ng hearts. 
Visscher concluded trom these di.f'ferancas that fat was a substrate that was 
ut:Uir.ed by the heart. Cruickshank am Kosterli tz (1941), using a modifica-
tion of Bloor•s original method (Bloor and Snider, 19.34) ra;1orted the first 
direct evidence or rat utilization in \ha aglycemio isolated rat heart. 
They determined that the heart utilized ta'ity acids both :trom heart muscle 
and blnod. These findings negated fletcher a:rd Waters• (19.38) earlier 
fimings that none of th:t blood !'at was t~t.ilized b1' the heart. 
In 19491 Bing and associa._.s reported a method tar coronary ainus 
cathe,eriza1iion in the in'tact dog ard nw.n. Using this me1ihod, Bing !! Q, 
(1953) raponad studies on JV"OOS.rdial carbo}Vdrate metabolism of the human 
heart and found th.at the total aerobic metabolism. or glucose, lactate and 
pyruwte combined fall shor1; or the total J'ltY'Oe&r<U.al ooc.ygen consumption. 
This timing suggested •hat \he hlll&n hea~ also used non-carbohydrate 
subs'\ances tor energy production. In 19541 Bing !1 IJ:. in11iially deiiermined 
that \he u ?1!:2, human heart utilized tree tatty acids (FF A) and that \his 
substrate con•ributed aignU'ieantll' '\o the oxida\ive metabolism. ot the 
myocardium. 
The reports b.r Bing and co-workers taken toge\her with maiv observa-&ions 
by other laboratories (Finkels'fiein !1 !l,, 1960J Goto, 1962; Gordon am 
Cherkes, 1956; Carlsten !!.!. ilt 1961J Gousios am Felts, 1963; Olson, l.959; 
ani Shipp and Opie, 1960) indicated that f'at utilization by the heart, 
specifically FFA, was no longer speculation. 
More recant studies have round that en:logenoua lipids in the form ot 
triglycerides (1'GFA) also plq a major role in cardiac mau.bollsm. Shipp 
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!1 _. (1963, 196.4) repor\ed the first direct nidence ot endogenous lipid 
utilization ot the isola'hd pertused rat heart. They found 'iha'i sodi U11. 
palmitate-1J.4c extrao'8d by' iaolated cardiac muscle is first inoorpora\ed 
in~ TGFA, ]D"iar~ in \he c)"t.opla•• toll.and by the '1-anster ot the 
labelled FrA in1io mitochol'ldrial phospholipids prior to oxidation. Olson and 
Hoeschen (1967), using 'h• same preparation, wre unable 1io de'\ect changes in 
phospholipida whioh oottesponded 1io intraoellular oxidation.. These workers 
showed thai perfusion wi'bh a subatra'H-frH media until thrt oont.ractions ot 
the hear1i eeaaed, reduced 'fOJ'A content by ?0$ ot 'ihat originally" presern 
while phosphol.ipids remained. uncl'&npd, indicating '1l&t phoepholipids and a 
•mall por\ion ot the '1'11Jl.7eeride concen\raiion nre aaseniial tor the 
s1iructural integrity ot the oell aenbrane qaMm8. Denton and Ramle (196'7a) 
also found aillilar results. HOll9ftr, all 'hree studies support the role of 
trigl1'ceride-tatv acids as an endcgenoue su.bs\ra'h tOI! oxidation. 
The impor\anoe ot exogenous TGFA as a ••••"8 in -.rooardial metabolism. 
is presently ume\tl.ed. Gousios 11 ll (1963), De~on am Ramle (1967b), 
Regan !i 11 (1967) an:l Scheuer an:l Olaon (1967) have found that T<D'A are 
taken up by the iaola\ed perfused rat and rabbi\ hearis but as Scheuer and 
Olson poini out, their im.ponanee 1n situ ia questionable in the normal sta1;e. 
Hoft'Yer in certain pathological s•tes, these investigators postula\ed a role 
tor TGFA in myocardial lipid metabolism. 
B. CONTROL VECHANIS16 OF FATTY ACID TRANSPORT INTO THE MYOCARDIAL CELL 
Evans (1964) reported that 1iransport of FFA aoroas the cardiac eell 
membrane is a passi w process which is dependent on 1n1iracellular utilizat.ion, 
thus creating a conoen\ra'tion gradient favoring ent;r,r into 1ihe cell. This 
could also be accomplished by elevati~ the concentration of 1FA outside the 
cell membrane. lfowe9er, u reponed by Opie {1968) this process involves 
other require•n'\s since normal tissue levels ot rt.A. are approXima:\ely 20 
times higher than tba'\ ot blood. Thia could possibly be explained by 
intracellular '*aoceptors" or binding sites (ha.ns, 1964) llhi.oh ptq'sicall.7 
bind PFA mol.ecules prior to their acti•tiion '\a the acyl tOl"Jll. Inwacellul.ar 
processes which al.tier \he remo•l or fF4 frcmt these binding situ (esteriti-
cation or oxida1iion) oould also intluenoe menbnne \ra.nspon. The m.eoham8m8 
involved in JQ"OCardial PFA vanspcrb appear \o be more oc:aplioated 'Ghan merel.7 
elevations or nduc-C.ione in enra- and in1iraoellular concentrations ot FFA. 
Repons on the control at Fli'A enrac'1.on by "the heart haw sugges'ied a ramber 
ot possibil1t1eat 1) arterial levels emering the hear'\• 2) albumin - FF.A 
molar ratio• 3) FFA chain leng'ih and saturation, 4) coronary blood flow. 
and S) rate ot in\racellular oX1.dat1on. 
1. £i!ritl M!Dl1 
FiricelaWn !111 (1960), Ballard !1 IA. (1960), Ca.rls1ien !i I! 
(1961) and Scott !i 11. (1962) have shown th.at FF.A up'iake by the 1Jl !!l:2. dog 
and human heart is direct]J" related to the ar\erial comentration ent;ering 
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the heart. Evans !1 !l (1963), lfUlebrands (1964b) and Gousios !!. il, (1965) 
supported these findings in the isolated perfused rat heart. In the !!l lll:S!. 
experiments, (Finkelstein !.i Alt 1960J Scott !!. 11.t 1962; Cowley !1 !l• 1969 
and Regan !!.!, !!,, 1966 ard 1967) effects of catecholand.nes on 117ocardial 
metabolism 11Sre studied. Jforepinephrine and epinephrine were found by these 
laboratories to stimulate FFA uptake and oxida:tiion by indirectly elevating 
arterial levels. lo direct act.ion on cardiac ae•bolism was attributed \o 
the sympaitbetic amines. bans !i ... (1963) and Gouaios !! !l (1965) have 
shown a direct relationship be1WHn n'A uptake and eoncenttration ot the 
perfusate. Carlsten Ii 11 (1963) have also fourrl Bim\.lar results in human 
subjects whan &nerial FF.A leYels wre increased by ingesting high FFA 
emulsions. lum and Roaenbl'WI (1966) am Cowley .ti !l, (1969) haw reported 
however, that JQ"OC&rdial up'8.ke ot 1'P'A •• no\ rela'\ed to anerial levels in 
certiain experimen\al situations. The former lf01"1<9ra found increases in FFA 
extrac·Uon 111 th single injections ot aatecholaminea betore arterial levels 
"91'9 elevated. Foll.onng narepinephrine inhaions. 1.the lat'\er workers tound 
tha\ FFA Gldtraction and oxidation reained elevated when arterial concen-
trations aa wll aa hemodynam.1c paramettera bad ra1iurned to control levels. 
The primary role of arterial concetarations in ayocardial FF A transport may 
have been overemphasised. It is possible tha1i they may serYe as a source 
which provides a"l&il.able substrate 'Go other 'ransporl mechanisms within the 
heart during periods ot ir:creased me'8.bolic demand. 
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2. Albumin - PFA Volar Ratio 
Albumin-bound FFA is 1ihe principal form in which depot fat is 
transporled to various tissues far oxidation (Gordon and Cher.kes, l9S6J 
Dole, 1956; and Fredrickson and Gordon, 1958). Evans (1964) reported that 
by mainiudning FFA levels constant in 'the isolaiied rat heart, FFA up1'ake •s 
decreased When the molar ra'\io of FJ'A to albumin approached unity. 
Goodan (19S8a and b) found in studies wi'\h albain and FF.A, that there 
are approx1ma'hly 2? binding si'Hs on the albumin molecule tor FF.A. ho sites 
were round to have a ver-y high association constant, 5 sites With a lower 
association connant and approximately 20 al.Ma w:lth a very low binding 
capacity. Thie :repon could explain l'ftns' tindinp of varying albundn-n'A 
ratios. On \he other bard, Gouaios !111 (196S) found no change in FFA 
up'U.ke by the heart when the a)l)\Ri.n conoen'h"a'tion was altered in the 
pertuai ng media. 
The inrpOl"\anee ot illuain concen\ra'1 om in m;rocard:i.al PF A vansp~ in 
the in, situ heart is questionable sine• albmin concenra'1ons are maintained 
ex1ireme]3' constant in the bcdy. 
3. .,,A Chain Ienoh And ~11turatJ.en 
Goodman (19S8a) reported that the attinity of FFA tar albumin is 
in:t'lueneed by the cha.in length and degree of uma:\uration. Since this would 
tavor the transport or certain ratty acids in the plamna trom adipose tissue, 
it would also indirectly inf'luence fatty acids available tor extraction by the 
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heart. 'l'he nutritional state as well as the experimental species would also 
determine FFA present in adipose tissue to be mobilized. Ill !1!:2. or in vitro 
studies on the influence of chain length ard satura1i:ton would therefore, be 
difficult t;o interpret. 
This is exempliiied in the reportta of Ro1iblin a trl Bing (1961), Carlsten 
!.!, §.!. (1961), Harris !.i !l (1962}, Miller !!. !!. (1962) ard Willeb:rands 
(1964&). The authors agree 'tthat oleic acid is extracted. preterenilially by the 
heart Oftr other tatty &.,ids. Miller Ii ti (1962) report.ed tha'ti pal.mi.tic acid 
uptake in the 11!. !!:!£ dog hear\ is as high. as oleic acid With somewhat lower 
myocardial up1iakea ot stearic a:rd llnoleic acids. RoWin and Bing (1961) in 
a sbd.lar prepan;\ion showed palmitic and a'8ari.c acid uptakes well below 
oleic acid W1 th no linoleic acid upt.ake observed. In tba human hearii1 Ro'&hlin 
and Bing (1961) found oleic acid to be the Mjor ra•ty acid ex1iracted by the 
heart With significant but lower up'\akn ot palmi'\io and linoleic acids. 
Carlsten !! 11, (1961) ard Willebranda (196.4&) obaernd higher human Jll70CQrd1al 
oleic acid remo'Val than Jlcnhlin and Bing observed, but tau.rd no uptake of 
palmitic acid. 18.llebrands also found significant up'liakes of both stearic 
and linoleic acids whereas, Carls,en reponed. a nega'ttiw arteriovenous (A-V) 
difference tor linol.eic acid. Rotblin ard Bing (1961) augges'8d that the 
dU'teren·Ual up1'ake ot individual ra•v acids by the heart is governed by 
'bheir differences in anerial lB'ftl concen'\rationa en'liering ·U• heart. 
However, st.udiea in the isola:ied rat heart perfused w:1. th equimolar mi.Xtures 
ot the major fat.1iy acids dem.onstra'8d a consiswnt relattonship between 
ll 
molecular structure and uptake by the heart. Evans (1964) found that 
monoenoic acids (palmitoleic and oleic) were taken up in preference to 
saturated tatty aclds ot equal chain length. Willebranda (19641>) reported 
that myocardial uptake of sa1m.rated acids decreases as the chain leng"Gh 
increases and found that oleic acid was pref'erred over all other fatty acids 
tested. Wi'\h the information reponed on both the intact and isolated hearts, 
it is difficult to explain how Stein and Stein (196)) could f'im no 
preference tar tatt;yaeid exttraetion b;y the heart. 
Besidee \he direct nidence tor JIO"OCardial specificity of cert&j.n fatty 
acids, a 11Jaber ot observations also indirectly supporl the role ot the heart 
in regula'\1ng 1m1vidual ta1t'i7 acid q>take. Olson and Hoeschen (1967) have 
shown thlt then are mjor ditterenoes in the aonoent.ration ot individual 
FF.A in cardiac muscle llhen compared to the plasma concentration suppl¥!ng it. 
Cardtac muscle also e.xhibi ta a specificU17 for ra'V" aoida Which are 
incorpora'Md in'tto UJB urious lipid classes (Denton and Randle, 1967&J Stein 
and S'em, 1963). Niell an:! Masters (1968) have foum die'tiinet differences 
in phospholipid f'atty acids, glyceride ratty acids and free ta'\t7 acids in 
auboellul.ar trac'\ions ot the m.ne hear\. Lipase activity has also been 
localized in cenain aubcellular organelles (Riaaclc:, 196.5). All of these 
reports indicate '\hat imracellular s\ructures exhibit a specificity for 
cert.ain tatt7 acids which supports 'ihe ability of the heart '\o enrae'ti 
individual FFA at different rates. 
'11 II 
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4. Coronan; Blood F1ow 
The effects of coronary blood fl01r (CBF) on rqoeardia.l uptake ot 
FFA remains unsettled attar having been studied in both the intact and 
isolated perfused hearts. G011sios !1 !J:. (l96S) using the isolated perfused 
rat heart reported no change in FFA enraction when n.01r ra't;e was doubled. 
Cha.lloner and Steinberg (l966a) wre also unable to ft nd a relattnnship 
betwaen flow rate and fatty acid ex\ract.ion in the isolated rat heart. Namm 
and Rosenblum (1966), using the in !ll.s?, dog heart sugges1ied tha1; in::reased 
CBF supplied FFA to the JTO"Oc&rdium du.ring increased. work prior to increased 
arterial lft'els ot FF.A f'rom &di.pose tissue. Cold.ay !! BJ:. (1969), using the 
intact unanes1ihe1iised dog, reported simllar obaenations when sustained 
inf'usions ot norapinephr:i.ne irereased J'FA uptake with no change in arterial 
levels. Howver, the same laborator.y using smaller doses ot norepinephrine, 
reported earlla (Gold !1 !l,. 1965) \hat CBF had no effq1; on the norepine-
phrine-s\imul.a ted myocardial extraction ot n .. A and Vw.t i'ti was rela1'ed only 
to increased a~erial FFA levels. 
The discrepancy in resul ;,s at iheae investigai;crs may be due \o 
differences in a:per.l•n'al preparati.on (ll! !J:.!2 !!.• !!! 'ti.Vs?). However, it 
is very difficult ~ increase CBF :ln 1ihe intact preparation witho~ tbs use 
ot exogenous pharnacologleal agents or neurogenic stillUlati on wh..1.ch in 
themselves might atf'eat cardiac metabolism directly'. 
5. Ra~! Qt InttacellY:fAr Qtgdatiop 
The rate of intracellu1ar oxidation of FFA has been shown to 
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influence the passive transport of this substrate across \he cardiac cell 
membrane (Evans, 1964). Factors whieh would affect oxidation of l"FA should 
therefore have similar ef'feots on FFA transpor1i. However, maey eonfllcting 
reports have not been able to clarify this problem. Gousios !.!. Al. (1965) 
reported that norepinephrine and epinephrine increased the oxidation of FFA 
taken u-o by the heart but did no't alter the amount enracted,. Kreisberg 
(1966b) observed an increased erdogenous lipid turnover with epinephrine but 
found no stimulation of ~xogenous f'atty acid upiake. Cowley .ll 11 (1969) 
tound increases in FF.A. uptake and oxidation during norepinephrine infus:i.on. 
Challoner am 3'\eimerg (l966b) repor'\ed an increase in myocardial oxygen 
consumption W1 \h epinephrine accompan:ted b7 a r:tse in intracellular FF A 
concentration. The stimulation in ax:ygen consumption resulted from an 
increased oxidation ct intracellular FP'A (Oballoner arrl Steinberg, l966a). 
This was the tin'\ evidence reoorted ot a direc\ stimulation or m;rooardial 
oxygen consumption by epinephrine indepen:lent or he:m.od'.rnamic: aha~es, since 
the erper:tments were performed in isolated perfused ra1i hear'&s 'llhich were 
arrested wi\h x+. 
The conflicting 9Vi.denoe thus presen~d suggests other mechanisms 
involved in FFA transpor' lllhiah are unclear at \his time. Many int.ermediate 
reactions in m;rocardial lipid metabolism haw ye\ to be clarified before the 
exact mechanism of transport ia elucidated. The role of carn:l.iiine is just. 
one example. Yarquis and Fr11iz (1959) tound heart tissue contained very 
high concentrations ot oarnitine. l'rit.z and Kaplan (1959) repor'8d 'bha'\ 
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carnitine directly stimulated FFA oxidation in rat heart homogenates. Thq 
have also found that carnitine does not affect the ac1iiYation of tatty acids 
to tre acyl form, but seems to !unction as an intracellular mechanism tor 
transport of acyl .fatty acids. 
The impor\ance u •ll as controlling factors on carnitine action !n ill!!. 
is not known. but if it serves to C&l"I'T 1'F A molecules intira.cellularly t.o si tea 
of oxidation, it ma;r provide a very iaporiwlt step in lllTOcardial FFA U-ansport 
into the cell. 
C. CYCLIC 3' 15'•.AMP, CATECHOL/l'MINES AND THE P-AIJRENER.GIC RECEP?OR 
St\dies on \he mechantsm o.f action of sympa.thanime'\io amines and 
glucagon on phosphorylase activation led to the discowrJ of cyclic 3' ,5 1-
adenosine monophosphate (c-AtJ.P) in 'ftll"ious tissues. (Cook !ill• 19S?, 
Sutherlard and Rall, 19S'1J Lipkin !1 M:,. 1959J and Sutherland and Rall, 19,58.) 
In further studies it was .t'ou:nd that the cyclic rmeleotide was formed from 
adenosine triphoaphate (ATP) b7 the vg-M- cata]Jr'zad action of adeqyl <..>yclase 
(Sutherland !! §l, 1962a am Rall and Sutherland, 1962b). Once c-AMP is 
formed it is rapidly' inac,iva"8d by phosphodiesterase to 5'-AMP (Butcher and 
Sutherlam1 1962d). Butcher and Sutherland (l962d) alao reported that meteyl 
xanthines, (theophylline, theobromine am caffeine) •re effective in blocking 
phosphodiesterase 3c~ivity With theoµl.iylli.ne being the m:>S'li potent. 
Reports on ade:qyl cyclase activity in various tissues have shown that 
avian erythrocytes are able to synthesize c-A)[P (Sutherland li il,.t 1962&.) 
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but do not have the ability to inactivate it since phosphodiesterase activity 
is absent (Butcher and Sutherlard, 1962d). 'l':ivoren and Sutherland (1963a.) 
\).sing the avian e:rythroeyte preparation fomd that the 1-isomers of isopro-
ttn•e:rol, epinephrine and norepinophrim wero affective in stimulating c•AUP 
production. These authors (Davoren and Sutherland, l963b) alsc re;Jortetl ·;hat 
adenyl cyclase activity was located in oonjunc1iion with the cell IJembranes of 
both the avians red cell and rat liver cell. It was also shoKn ~n this study 
th':'i.t as the structural ln\egl"i'\y ot red cell and liver cell membranes was 
destroyed by pressure homogeniza'b.l on, aden;rl cyolaso aeti vity dimi1li.ahed. 
This would sugges1i that a certain conformational pa1i\ern within the highly 
ol"ganized framework of the intact cell membrane is necessary for the enzyme 
to be l\Ctivated by hormones. r/rye and Suiiherland (1966) have reported that 
the active site of adenyl cyclase is locat..ed on the inner portion cf the cell 
mmubra.na since addition or ATP am Mg# bad no measurable ef'i'eot on c-AMP 
production in the intact cell, even in the presence at epinephrine. 
The stimulation of adecyl cycla.sa activi t7 by sympathetic neurotrans-
mitters (norepinephr:tne and e¢.nepbrine) as nll ae marked stimulation by 
isoproteranol supports tbtl possible involvement of adertrl cyclase in 
sympathetic nerve activity. This was .rurther sttpporiied by 1ihe use of 
adrenergic blocking drugs dibenzyline and dichloroisoproterenol (DCI). 
Murad et il, {1962c} found that stimulation of c-AMP production in dog hear'\ 
homogemtee was blocked by OCI. Davoren and Sutherland (l963a) reported 
similar observations on pigeon erythrocyte prep:ara,ions but found no errect 
with dibensyline. 
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Since the original classification ot adrenergic receptors into alpha and 
beta types (Ahlquist, 1948 am Furohgott, 1959), nlimerous repons d-.J.ing 
with their ac1;iona on Tarious tissues haw toll01ll'Wd. Al'ihough the exac\ 
nature of these recepton is no'\ known, ~ use at agonists and antagonis1is 
have functionally- separated their activi1ties on a •chanical and m.e\abolical 
basis. The inhibition of oa1techol&nd.ne-s1timula'8d o-AMP produc'\ion b7 
jkld:renergio receptor antagonists such as DCI and pronethalol (Ponll and 
Sla 'hr 1 19'8 am Black and Sitepbenson, 1962) and '\he lack at an effect ot 
dibensyline, an <*adrenergic reoep'\or antagonist (Jfiokerson and Nomaguchi, 
1951), suggested \ha\ \he ad.81\'rl orcla•• qe'kta -.y be imponant in tissues 
which respond to aym.patheUc nene stillUlation nch as adipose tissue and 
cardiac m.uacle. This response would appear to be mediated by P-&drenergic 
recep\or aeti Ti v. 
l. Adipo@! !i&SJI 
BT uu of uni.lateral aplanchnic nene seotion11 Beznik ard Hasch 
(1937) tound a 100-300 per cen1i increase in perirenal fat wigM on ~· 
denervated aid•. Thia •• the tirs1t direct ertdence that s7111.P&thetio n81"ff 
activitiy was impor\ant in maiM&ining the qn&Jlic •'-bolic ac'\ivity ot 
adipose 1;1saue. Bawl and Goldtein (1959) adJl1nia\ered norepinephrine and 
epinephrine and too.rd inor••.S oirculaUng lnels ot l'FA. in humans and dogs. 
They also toum th&'\ hexamethonium inhibi\ed FFA :release trca adipose tissue 
in adrenaleotomized dogs receiTing consta.n1i infusions of palmitic acid-l-l4c. 
LeBoeuf li ll,. (1959) found tfhat epinephrine direct~ s1i:i.mula\ed FFA release 
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from adipose tissue s'tudied in n.tro. Thia •s one at the first observations 
to relate metabolic responses to stimulation of adrenergic receptors. 
Vaughan (1960) supponed this observation i!l vitro and also observed an 
increase in phosphoryl&se activi1;7. However, Rir.ack (1961, 1964) and 
Bj&rntorp am J'ura.n (1962&) reported the presence ot a "hormone-sensitive" 
lipase in adipose '1•8U• which could be atimulawd by epinephrine and c-AMP. 
It was concluded \hat this lipase increased TGF.A degradation and released FFA 
and glycerol tran adipose tissue. The lipoqtic qnerglam be1iwen epinephrine 
and catfeine, "1le latter aa an inhibi1ior ot phosphodiesterase, indirect]\r 
supported Rizack'a atudiea (Vaughan am Steinberg.t 1963). Butcher !1 §! 
(1965. 1968) reponed an increase in c-AVP produotion ooncomitant With 
increased lipo~aia in response to epinephrine administration to epidi~ 
fat pads and isolated rat cells. They alao tound '\bat DCI and pronethalcl 
were e.f'fectiw in blocking these responses. Exogenous adm:lnis,ra1iion or c-AMP 
had no effect on FFA release, hnever, the d1but)'l'1'1 derivative ot e-AMP 
(Poa'9mak !.i U.. 1962) J1&11cadl;r increased lipol1ais. This •• also confirmed 
by Peterson U.11 (1968). The ditterenca in c-AMP and dibut;yryl c-AMP 
(Di-cAMP) reaponaea _,. be due to the inability ot phosphodiesterase to 
inactivate Di-cAMP (Postemak 1111- 1962) or 1io the difference in cell 
membrane permeability ot Di-cAMP (Robison !!_ !h 1965). Howner, Blacher 
li ll. (1968) have found phosdies'Mrase '° be equally' e.f'tective in the 
inactivation of both c-AMP ard Di-cAJJP. They also reponed a 87nergism with 
metby'l xanthines arxl Di-cAMP. It would therefore appear that catecholamines 
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stimulate lipolysis by increasing intracellular c-AMP levels through a.ctivatio 
of aden;yl cyclase. Tha elevation of c-AHP ac1iivates the "hormona-sensi\ive" 
lipase resulting in the degradatiion at 'l'GFA and release of FFA (Steinberg, 
196.3). In addition, l)-adrenergic reoep'k>r blocking drugs should inhibit this 
reaction. Pilkington !!, !,!, (1962, 1966) using various ,_receptor agontsts and 
antagonists have imirectl,y conf'irmed this in man. 
2. cm1ac •w1 
Ivana and Ogawa (1914) ard Ivana (191'7) were the first to observe 
alterations in •'8.bollam ot thl isola'\ed Jll8.Jl'IDl&l.1an heari in response to 
epinephrine. They- found a marked inereaae in oxygen consumption With a 
concomi'8.nt lonrir:g ot the R. Q• Which was •'1iribuwd to the delay in 
intermediary reactions of oXidatdon which occurred before complete axidatdon 
to co2 took place. Thl7 did not consider \ha'i an imreaae in rat utilization 
m"ight have occurred. Finklea'Hin !.i 11 (1960) towd elevations in uptake and 
uUlizatl.on at FF.A by the intact dog hear"\ in response to norepinephrine 
inf'usions which 'hey aasocia'\ed 111.'h inoreaaed ar\erial levels and increased 
CBF. Gold !111 (l96S) found imreaaes i.n FFA up'4lke am oxidation, but no 
change in CBF wi\h norepinephrine infusions. CoWJ.e;y !i §l (1969) reported 
that norepinephrine increased ff A uptake ard md.dation which tha7 associated 
Wi:t;h elavations in CBF since ar\erial FFA concentrations wre unchanged. 
Gousios !.ill (1965) and lreisberg (1966b) have also found contlicting results 
in the isolated rat heart (see chapter I, sec1iion BS), however, both fird a 
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positive effect of ncrepinephrine on .rqocardial f'atv acids. Ribeilima li iJ:, 
(1964) also reported increases in ~ooardial uptake and oxidation in response 
to norepinephrine in hsaltey human subjects. They have also attributed t.Jiese 
changes to elevations in arterial FFA concentrations. 
Although arterial levels were thought to play the major role in the 
myocardial metabolic response to catecholamines, reports from Su1iherlard's 
laboratory have promp\ed a reevaluation ot \he processes involved. Studies 
by Sutherland ll.11 (1962&), Rall and Sutherland (l962b), Jlurad !i M. (l962c) 
and Butcher and Sutherland (l962d) have shown t.hat cardiac muscle contains 
adel\Yl cyclase Which can stimulate Uie producUon of c-AVP in response to 
norepinepbrine1 epinephrine and isoprot.erenol. OOI, but not dibenz7line, 
blocked tha catecholamine-atillula '8d p:roduc'\ion of c-AMP in heart homogenates. 
Appreciable q;mm\i ties of phosphodiea'\erase wre also tound in cardiac let\ 
't1tntricle Whioh could be blocked wi\h theop}cy'lline '\o give a qnergistic 
affect on c-AVP with catechol•inea. la• and Jfqer (1968) have contil"llled 
these findings in dog and ra1t heal"U trosen al!B and tou.Di that p:ronethalol 
blocked the epinephrim-i.nheed r1ae in '11• c-AMP concentration. 
The imponanoe ot thla system in JIG"CC&rdial lipid •taboli• waa 
strengthened b;r the obaervatt.on ot Bj!l"n'k)rp and hrman (19621>) ot a "bormone-
sensitive" lipase in rat heart aUBola which inareaaed triglyceride degradation 
when a1imula'8d by epinephrine. Recent evidence also suggesis Vtat a mono-
glyceride lipase (Yamam.ot.o and Drumm.old, 1967 and Biale !ill,. 1968) Jlll7 also 
be imponam in myocardial lipolysis and i u actiTi ty UT be epinephrine 
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sens:i ttve (G0rtn am Sha.t'rtr, 196?). Both t:10 monoglyceride and triglyceride 
Ji.pases are distinct from the lipoprote:1.n lipase rnported by Korn (l955a, 
l955b). Mallov and Cerra (1967) eo1lld not demonstr.ite & short term lipass 
actintion by epine?:>hr:!.ne in thair myocardial lipase preparations w1'.ioh 
corresponded t.o that foam by Bj&rntorp and Furman (1962b). However, the 
long tern. effect 11as blocked by f3-tldrenergic reeev'°r blocking drugs and 
1:n.1raey-cin which led these authors 'tao conclude 1that cardiac lipase was noi# 
aeti va'\ed by c-A.MP but. acu in SOll9 ma.nner to s'iimula:tie 'the S7tl1ihesis or the 
enz,... The sigrd.ficance ot t.bese timings is unclear at this '\ine, ho.,..,.:r 
it seems unlikely that. an increase in nvocardial lipase aattn:ty wou.ld be 
solely dependem on eDZ1"J19 synthesis since \he he~, which is mainly a lipid 
u1tilizing organ in the poetabsorpti.ve stat.e, is s'Ubjec'i to very fast alter-
ations in i'8 metabolic requirements. The intpo11ance at endogenous TGFA as a 
substrate in cardiac metabolism (see ohap'8r I, seciion A-l) would 1ihere:f.'ore 
require very rapid changes in lipase ac1d.:vi ty. Purtblrmore, peak in::reases in 
c-.AMP conoentra"1ona in rat lean induced b;r epinephrine occurred w.t.:thin 3 sec 
:t"ollowing drug adminis'\ration (Robison .t1 Alt 1965). Since 30 minutes was 
the shortest 'time of U!. !itro nea.surement. of lipase acii.vi'fiy in response to 
epinephrine mad• b;y Mall.ov and Cerra, 1'\ is doub'5ful they would have observed 
changes in "hormone .... ensitive" lipase activ:lt7. 
The imponanae ot P-&dnnergic recep1Ktr activity in the hean was 
originally reported by Ahlquist (1948)" However, the studies on myocardial 
13-adrenergic receptor aet:l vi ty that followed main.:cy- deal 'ti With hemodynam.t c 
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alterations (McKenna !!. AJ,., 1966; Nakano and Kusakari, 1966; and Whitsitt 
and Lucchesi, 1967). Metabolic responses to ~drenergic receptor activity 
in the heart have been indirectly studied by using catecholamines (see 
Chapter I, sectton B-5) and 13-receptor antagonists (Marchetti il !J._, 1968 and 
Satchell et al, 196S). All of these studies have suggested ~receptor 
involvement in J!\Y'Oe&rdial metabolism, however, meehani.sms by which this might 
occur have not been report;ed. 
The close relat:tonship ot adenyl c,.clase aoti Ti ty in avian erythrocytes, 
adipose tissue ard cardiac muscle in response to agents which show specificity 
to the fl-receptor has prompted Robison ti, !! {1967) to suggest that the 
13-adrenergie receptor is aden;yl cyclase or an integral part of this system. 
A summary ot this Ill.'tchaniarn is diagramDBd below (Sutherland !.?_ !l.• 1968). 
-Catechola:rnines 
fJ-adrener~ blocker:J.~ 
Ade!\rl 
FIGURE l 
Other 
Actions 
Methyl 
Xanthines 
f Phoaphodieneraae 
ATP _(!.,p ___ ...,~ c-l@re ------1----il>, ... ~· AMP 
..,.~olaee 
'II 
I~:a~:• ----~;:.. 40'1v11'1.-e 
Trigl.)"cerides.. ~ fF A + glycerol 
SUJllllU'Y ot so• imel"'.l'"elatiomihipa irm>lvtng c-AMP 
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CHAPTER II 
MATE2UALS AND ME!'HODS 
A. ANESTHES!.A AND SURGICAL PREPARATION 
Healthy mongrel dogs, taeiied tcr 18 to 24 hours and weigh.1.ng trom 15 to 
24 Kg, were ams-.he\ised 111 th the in\ravenoua adminiatra'\ion of sodium pento-
barbi\&l (30 mg/Kg). ill major surp17 •s done wtth a hot eau'Gery knife 
(National Cauter)" model 92.>). A 'firacheo'\omy was performed trom a mid.line 
neck incdsion and the vagosrmpa•hetic ne"8 Vu.nks were isolated and sectioned 
at the level ot the 1;}\y'roid oari.i.lage. Additional anasthesia was admlnistered 
when needed. To ensure adequa'k bJdr&Uon. '\he left femoral vein was 
carmulated for a slo• in.fual on of 100 '\o 150 ml ot o.9% JfaCl solution. The 
ehei:r' •• opemd in '\he let\ Sth int.erspaee J 'fihereafier ar\iticial respira'\ion 
was maintained With an Insco model lllJ-411 respirator. With the lungs 
retracted, the pericardium wae incised and the hear\ suspended in a peri-
cardial cradle. To prnent the coagulation of blood, all dogs were given 
5 mg/lg or sodi\11l heparin by 'Nin exoep\ Where apeeif'ied. 
1. 4-v DUf'eren;e Studia 
The coronary sinus •• cannula1ied Yla the left jugular vein Wi'\h a 
large bore me'al cannula. A thread was placed around 1ihe coronary sinus to 
constrict the ostia a.roum the opening of the cannula. Coronary sinus .t'low 
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was returned to the animal by means of a metal camula inser\ed into the right 
jugular vein to a point approximately 2 cm trom the right a1irium. A glass 
T-tube was in'ierposed betwaen the two cannulas to collect coronary sinus blood 
samples an:l 1io measure directly, W1 th a graduated cylinder and stopwatch, the 
coronary venous outflow at predetermined periods. Arterial blood samples wre 
collected from the let'\ femoral artery except where specified. Alterations in 
cardiac metaboli8m ware hued on changes in up'tiake which were cal.cula1;ed by 
multiplyi.ng &nel'ial-corom.r.r venous blood ditf'erensea (A-V) times the 
coronary sinus flow expressed in cubic centd.meters per 100 g or left 
ventricular auacle per mimw (Herrmann, 1926). Tba ex\ractton ra'\io 
expressed in per oen"' wu calculated tl"Oll. the A-V d1f'terence ot a blood 
metabolic •'li>•tnte dinded bT \ha anerial level ot the aubs\rate and 
multiplied b7 100. 
Hemodynamic par.-wra wre mord. tored in both 'h• propranolol - atrial 
tac}Vcardia and propranolol • norepinaphrine studies described below. Lett 
intraventr.l.oular preaaUN was recorcled frOfl a ca'\he'ier passed in'tio the let1i 
venU'icle Tia \ha let\ ocamon oaro-.id ariery. The left temoral ar\917 was 
oanmla\ed tor recording sys'iolic and diaa'iolic blood preasurea. Pressures 
were measured W1 th Sanborn model 267 AC a\rain-ga up tranaduoers and wre 
recorded cont:tnuoualy on a Sanborn model 4560 photographic recorder. Heart 
rate and rate of left ventr:i.cular systolic pressure development (dp/dt) were 
calcula'tied from w pressure '\racings (Ranes !!. 11• 1960). 
.u. Proprano1o1-.."1.t•ria1. Tachyci;i.rdie 
ThA eff eets of '3-adrener'."'g:tc recoptor blockade or. myocard~ al 
r.otabcl'lsn· were stud~.ed 1ri 19 an:trna:J.r;. nteraticns in metabolism .rero based 
on changes 1.n A-V hloot1 differences of ax;:gen, glucose, lactate, PY'I"'..lVate and 
F11' 1\. P:t~.ot expartrients with val"'l;i.nr, doses of propt"enoloJ. (0.5 - 2 ~<g/Kg) 
shower'! that. doses lrl.gher than '.l mr;/Kg r~sul";ed 1 n seve:r'e cyocard1.al depr<:is-
s'.1 on. When the dose rs. rged f"rom 0.5 to 1 mg/Kg, cardtae responses to stellate 
ganglion stilau:Uttion were eli.Jnimted noncurrent llT th a m:inimal degree of 
cardiac depreeaton. 
The effect of P-adrenergic receptor blook:!:lde on cal"H.a.c metabolism was 
C!eteniined trc:im blood sanples taken during a control period and 10 minutes 
a.f'ter the i. v. administration or l mg/t~ of propranolol. Concnrrd.tant 
hemodynamtc changes •re recorded before and 5 and 10 min &ner treatment 
with the ~locker. Atrial tach)"cardia was then induced far a period at 3 
nrl.nutes, during which time hemodymmic paraae'\ers were continuously recorded. 
At the 8M of the 3 minute period c:-1 tachJca.rd'4R,. blocd. samples were 
collected. Fif'\een nd.nu'9s at"hr tachycardia was \erminated, the recowry in 
hemodynamic parameters as recorded. In two of 19 doge the effects or a\rial 
tachycardia on henodynamics an! lll,7'00ardial stlbstrate uptake were studied prior 
to the administratie-n of prcipranolol. In tour of 19 dogs 1 oxygen content as 
detarmi.ned in blood samples collected anaerob1.call;y in chilled syringes and 
placed immed:tately in ice prior to analysis. Stimulation was maintained with 
square wave pulses for 3 minutes from a model S-4 Grass stimulator. 
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Stimulation ra~ed trom 4 to 6 V with a delay and duration of' 3 maec. During 
a control period and in the course of P-receptor blockade, the frequency ot 
stimulation was adjusted to raise the heart rate by approximately 50 beats/ 
min. 
b. PJtopranolol-norepinephrine 
In open ches\ dogs w:i'\h perloardial suspension ot the heart, 
the left circumflex OOl'on&IT arhr;y was canmala'hd cloae to its origin from 
the left oOJlllOn coronar,y an.r,,.. Blood trm the J'igh' t mn.oral artery .. 
divened '\o 'he cClll"Onar;y artery, whDae la"9ral perfusion pressure was 
m•aured from a T '\ube. 
In 20 non-tasted mongrel dogs, the u'tiabolic effec'\ or norepinephrine on 
the left ventricle _. determined by intuaing into the circumflex coronary 
artery with a Harvard Intuaion Pump (aodel 97S), 0.02 "°g/min per Xg ftight ot 
the animal for 10 minu'\es. Wi"1lou.t interrtlpting coronary flow, ncrepinephrine 
was delivered close t;o the opening ot the let'\ circunrtlax coronary aner,y from 
a PE 190 po]¥e•h;rlene ca1'he'9r thr•ded trca a T tube loca1ted in '\he d.iver'Md 
temoral-circumfla: coronary anery now circui\. In pilot experiments higher 
doses t£ nonpinepbrine wre observed "tio grossly altar h!tmodynan:ics., while 
lowr doses did not give ev.tdenoe of metabolic at.imulation from m;yooardial A-V 
blood diti'ere:noes. In 10 ot the 20 dogs, norepinephrine was infused lD 
minut.es after \he 1. T. injectton of l mg/lg of propranolol. .Alterations in 
m;yocardial uptake of glucose, lact.ate, pyrllft\e am rFA wre de\ermined in 
'Z1 
blood samples simul'\aneous~ drawn during a control per! od am 8 to 9 minutes 
after the siarl ot the norepinephrine infusion in trea't;ed and non-trea\ed dogs 
with the ~locker. 
c. Dibutyryl-c-AMP 
The possibility that di-c-AMP was able to reverse the effects 
of' propranolol was studied in 4 dogs. My'ocard'W. WA up\ake •s determined 
.from arterial am coronary sinus blood aanples taken during a control period, 
10 nd.nu'Ms af\er the 1. v .. injection ot l mg/lg of propranolol and s, 10, lS 
and 25 mim\es attv the i. v. injection of 2.?S mg/lg of di-c-AMP during 
,_.drenergio reoep\or blockade. 
d. Aner!al Levels 
To evalua\e the af'tecta ot a:Merial lwels oonccai:\ant with 
P-adrenergic reoep\or acti 'Yi '1' on JQ"OC&rdi&l •ti&bolia, anerial n A levels 
were elnated 1:v' intuaing imo tm left cireumf'lu: anery increasing concen-
'\rations of a N&-PQlmi t.a '8 albumin solution. Thia •• aoecaplished by' 
pertwsing the oirewaf.'le:x coronar.r anery with blood from '\he taoral ane17 
as described ab.,.. Two T tubes wwe placed in this dinned circuit, one 
very close to the teaoral anery and another close to '\hit oircuat'lex aneey. 
The palnd.\a\e solution was infused Tia \he T tube located near the femoral 
artery llhile arterial blood samples tor dnenainaUon ot FFA conoentra'\ion 
levels wre W1 thdrawn from the T tube located near the circumflex. This 
technique pemitted m·;xing ot the tatty acid solu1iion With arterial blood 
before en'tiering the coronary circulation. 
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The Na-palmitate-albumin stock aolution was freshly prepared before each 
experiment by combirdng the Na-palmitate with a 9% albumin solution prepared 
with isotonic saline. (Bovine albumin (Frac'Gion V), fatty acid poor, was 
obtained from :Nu:t;ritional Biochemicals Corp., Clevelarrl, Ohio.) The solution 
was emulsified by sonication an:l bad a %hl FFA-albllltl.n molar ra-.10. .At this 
concentraUon \ha palmi\ate, rather •han being complexed '\o albumin, is 
s'\abilized by albumin (Bezman-Tarche:r, 1969). Af\er ~ng control A-V blood 
samples tor 1".A anal.1'sis and CBF, l.O, l.S and 2.0 ml ot the palmi.tate-
albumin stock aolu1iion as dilu\ed \o 10 ml with the dog's arterial blood and 
infused suoceeaively a'\ a ra1ie ot 1 al/min by a Harvard Infusion Pump. A-V 
blood samples and CBI' wre 1aken at'\er infusing tor S llinu.1ies a'\ each 
conoemra'\ion. This •• followed by the injec'tiion or l mg/lg of propranolol 
in one group ot tour dop or adding to \he infusion solution aufficient 
norepinephrine to deliver .02 '1g/lg/atn in another aroup or 4 dogs. In each 
group, control A-V blood sanplee and c:ar were \&kens l) 10 minu1ies af''\er 
~lookade or 2) during \he no.1'9pinephrine infusion With no palmiute added. 
Arterial levels were '1mn imreued in •ch group ard blood aaples and now 
taken at each auccess1ve increase in conoen\ration. 
Although prevlous s\udies haw tourd 'hha1i intuaion ot soap solutions 
(Na pahd'\ate) gave rise to clc\ting and he:mol;rsis (Connor .!i !l• 1963J 
Hoak .!! U• 1964 and Severeid !! !l• 1969), no evidence ot olottillt or 
hemol.ysia was observed, even after increasing aner:ial concentrations 
by .300%. 
2. Subc~illular Studies 
E>:periments wre performed to evaluate the effects of jhadranergie 
raoeptor blockade and si;imula tion on myocardial subcollular FF A. and TGF A 
concentrations as well as on the incorporation of Na..palmita'\e-l-14c into 
FFA, TGFA ard phospholipid components of the cell organelles. The s'\udies 
were divi.ded into three gro1pa of dogss l) cont;rol. 2) propranolol-treated 
dogs and 3) norepinephrine~ntu.aed dogs. The left femoral vein was 
cannula1'ed tor norep:lnephrine intusi.on. Tissue tor these studies was excised 
atwr comple•ion ot experimental procedures b7 clamping the pulmonary ark17 
and immdiatel,- ramming the entire lett venvicular Jl\V'OC&rd1um. Alterations 
in llO'OC&rdial metaboliam were baaed on substrate changes determined in the 
subcellular trao'td om. 
a. Concen'\ration Studiea 
In 'ihe control proup, tissue wu excised tor analyBis 15 
minu"Ms at\er the thoraco~ in 6 dogs• 10 minutes a.r-.er the i. v. injection 
or 1 mg/lg of 'Ule IL-blocker in the propranolol group (S dogs) and 10 minutes 
atter initiating an 1. v. int'wd.on ot 0.2 tJ,g/Kg/m.n of norapinepbrine in 5 
dogs. Thia dose or norepinephrine was alao used by Gold !! il, (1965) and 
found 'Go have arlced me1;abolic ef'feo'• wi1ih no significant alt.erations in 
hemodynamica. Heparin was not admird.S\ered 'lo dogs in this aeries of 
e:x:perim n\s. 
b. :P.ad:loi~otc~ ~turlies 
After initial surgical preparation, the i.ef't circum.flex 
~oronar;:- a!'tery W'al'l cannula·!;ad close to its nrigin from the left common 
coronary artery. Blood was diverted from the right femcral artery nth 
.3/16" (I.D.) 'Ygon tubing for perfusion of the coronary amry. Without 
interrupting ooron&.l"y flow, Ra-palm1\ate-l-l4c was infused into the heart. 
from a PE 190 polyethylene cathe'\er threaded from a T tube placed in the 
diver\ed .f'emaral-coronary anery perfusion circuit. The labeled pallnitic 
acid was intl"Oduoed close 'to the temoral anery which would penni t mixing 
betore entering the circumf'lex. 
30 
One m.Ci ot Ha-pal.mi tate-l..l4c was ob\ained troa \he New Englard Nuclear 
Corporation wt~ a specific aoti 'f'1 ty ot a.o mCi/mM. A stock solution was 
prepared by adding 10 ml of a 3. '7% albumin-isotonic saline solution to the 
isotopically labeled compound ant aonioating the mi.Xture until complete 
emulsion had occurred. This represented a %hl pe.l.JniU.te .... lbumin mola.r ratio. 
The stock aolu1don was sealed and kep1i trosan at -200 C between uses. One 
half ml or 50 µCi or the stock solution was diluied w:t th 4 • .s ml or the 
experimental aninal•s treshJ.T drawn arterial blood. This was mixed thoroughly 
and infused with a Harvard Infusion Pu.mp (JllOdel 97.S) a1; a rate of l ml/min 
1dth a total infusion 1d.m.e of 2 l/2 nrlnuies. This would represent a 2.8 
µEq/min increase in the amount or n A delivered to the heart. If a FF A 
arterial level of 500 p.Eq/L is assumed in these dogs with a femoral-
circumf'lex flow or (:J) cc/min, a total of 30 µ.Eq/ain would be dell vered 1io 'the 
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}leart. By 1.nf'us·ing the isC>topically labeled eornpounrl (2.S µ.Eq/m:tn) a total 
of 32.S µ.F,q/min would be dellvPred to the heart, Wh1.eh in turn would 
:repreeert an increase in arterial level t'rm 500 µEc</L to 545 µF.qjr,,. 
In the control group (6 dogs), cardiac muscle •s immediately excised 
after infusing the isotopically labeled compound f «" 2 1/2 min. In the 
propranolol group ( 5 dogs)• 6 1/2 minutes after l mg/Kg of the ,_blocker was 
administered, the isotopically labeled compound was infused followed by 
subsequent excision of cardlac muscle. In the nm-epinephrine group (S dogs), 
the isotopieally- labeled conrpourd infusion was starWd 7 l/2 minutes after 
initiating a 10 minute infusion ot noJ'Elpinephrine (0.2 1.1.g,,.tg/min}. The 
tissue was excised following completion et the infusions at 10 minutes. 
(1) Excision and \1.aaue preparation 
.Alter ram.owl. ot the lett ven'\ri.oular iqooardi um, the 
tissue was rimed wi:\h saline to J'EIDOW as much blood as possible, out in1io 
smaller pieces an:! plaoed immtd1ately into a 100 ml beaker containing ice 
cold hanogenizing media (0 • .32!, Sucrose, .02 ! Tris and .3 X lo-3! MgCl2 at 
pH ? .S). The mixture was then plaoed in a l'Eltrigera\or at 4° 0 and the 
homogenizing media changed once at\er 1/2 hour. The epi- am endocardial 
connective tissue, superticial Yeesale and tat were removed in a cold roan 
at 2° C am discarded. Af"\er cu1iti.ng it in'\o very small pieces, the tissue 
was placed in1io a Harvard med el l4l 'l'ia sue Press and pressed 1ihrough the tine 
seive attachment (1 mm diameter holes) 1io remove connective tissue. The 
resulting m1nci:id M.:'Js11e was thoro,Jghl3r m~.xed and ap~rox:tmately lS.l to 18 .. 3 
grams were accurately weighed on a Mettler :\nalyt:lc.:l Ba.lanco rr,odel !16'!' • 
. ':. 25% horoot;enate (l part ti~1sue, 3 parts hcmogonizing m.edi um) was prepared 
by hanogenization lf'i th a Thoms model 42!?8-B Tissue Grinder, iJnmersed in ice. 
'l'he homogenizer has a 55 ml capacity glass chamber lrl. '\h a serrated tei'lon 
pestle. Chamber to pestle clearance was be\'!,veen .006 to .!X>9 in. Sufficient 
homogenization ms attained When the pes"le was passed S-10 ti:JJ'3S through the 
homogena. te at 840 ryn. The homogenate was then til tered w:t th light vaeuum 
through 6 lqers of 12 ply' che8S'1Cloth placed in a BU.elmer .funnel With a 
diameter of 9 l/2 cm. '?he filtrate was collected in a 25 ml graduated test 
tube packed in ice. Attar vacuum filtration was complete, excess filtrate 
was squeezed trom the gauze into a gradtaied test tube. Equal vo11.nnes 
(approximate]J 14..5 ml) were ir.nsferred in\o four SO ml ultracentrifuge tubes 
(PolycarbonaM, "Oak Ridge" Type) immersed in ice. The precipitate was 
removed tran the gauze, resuspended in .2S M sucrose and centrifuged at 300 
Xg. Tbs preo1p1.tate was discarded am ?.5 al ot the supernatant were added to 
the t11-.ra1le in each ultracentrifuge tube. Arter thorough mixing, 20 ml or 
the homogenizing m4dium ns la;red below U'le mix1nll"f.t prior to ultraoen1iri-
f~ation. 
r 
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(2) Ul.V&cen1irif'ugation 
Subcellular f'ractiona ware iaola wd by dif'feren\ial 
ultracentrifugation (Schneider ani Hogeboom. 1950) at 20 C in an In'Wrnational 
B-35 Preparatift Ulvacen1irituge With a fixed &Jltl• ro\or (model A-147). The 
f IGURI 2 
la.'red t11V&te cent:r1.f'qJed tar 
10 mnu\ ... ~ '700 g er,,,., 
I 
Nuclear Fractd.on 1iaklt up 
i.n 2 ml or 0.25 )( Sucrose 
e- -Superna "U.n\ crwle 111\ochon:lria.l trac\ion 
'aka up in ' ml ot o.2s • 
sucrose and oen1irif"age 10 
a oemrituge tor 100 
,, ain at 1051000 g 
' (30,640 ) 
1--
min d r g (U.650 ,,,.) 
I 
I 
Mi tochondrial traction 
-take up in 2 ml or o.2s 
K sucroae 
Superrataia- - - • 
Microsomal traction 
take up in 2 ml of 
0.25 M Suorose 
Supernatant 
traction 
Separation of dog heart homogenate into su1Jcellular fraet.iona by ultra-
centrifugation. 
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The pelle\s containing subcellular parlicles from the nuclear, mitochon-
drial and microso•l trac'\iona wre resuspel'ded in 2 ml ot 0.25 lf suoroae by 
sonication. The supernatan'\ traction was pooled in a 250 ml graduate cylinder. 
thoroughly mixed, and the Yolmae recorded. Precau'\ions wre taken '\o main\ain 
the '\enperatures between 2 1ic 40 c prior to lipid mraotion. 
(3) F.nraction ot lipids 
Lipid• were cnracted trom the resuspended nuclear, 
mitochondrial and mioroeomal fraeti ons by 11he addition ot 10 ml of extraction 
mi:rlure (Dole and Jleimrtz, 1960 and Goss and Lein, 196?) consisting ot 20 
voluaes ot isopropyl alcohol, S volumes ot heptane and 1 volume of 1.0 !, 
Jii304. The Jld.xture WU vigorously shaken intermittentl.y on a Vorkx: mixer 
(model 1-500-J) for 4 minutes. Six ml ot hep'4.ne and 4 ml of freshly prepared 
C02 tree wa\er was 1ihen added and the minure again aha.ken for 4 minuies. The 
upper hep\ane phase wu "moved attw low speed oenVifugation. transferred to 
a 50 ml screw-eap oen\rihge tme, sealed under nitrogen ant stored overnight 
at 4° c. Lipids trom 20 ml of the 111upematant trao1l1 on were extracted b;r 
adding 5 ml of supernatant to 12 ml ot f!IX'Sraetion Jllixture and vigorously 
shaking the components tor 4 minutes. This was fellowed by the addition or 
?.2 ml of he-ptane and 4.s ml or co2 tree wa-•r and shaken again. The u~r 
heptane pl'l...ase was removed af\er complete separation, transten-ed; sealed 
under m:tircgen and stored at 40 o. 
r 
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'fhe heptam phase, containing the lipid eomponents ct •he f cur subcel-
lular tractions, •s reduoed in volume to approximate:b" 200 &.1-L. This was 
accomplished by placing the samples in a 50° C water bath and directing a 
stream of r.d \rogen over each sample. Alter sufficient volume redu.c'tiion, '\he 
samples W'ere transterred frOJll the 50 ml cen\ritllge tubes to Chroma.flex Samples 
Tubes (Kontea, Franklin Park, Illinois). The oe~rif'uge tubes nre rinsed a'\ 
leas'\ 5 ti.mes w.l'\h 1 1io 2 1111 or hep1iane which was \ransferred to the 
Chrom&flex Sample Tubes. Aft.er vol'Wll reduction •• completed, the sanrplea 
were sealed under nltrogen, vollDSs recorded am lipids separa'\ed by thin-
layer Ohrcaltogr&phJ'. 
(4) Th.in-layer ahromatograpey-
The 1;hin-l.ayer plates used in these experiments were 
pNpared from either Silica Gel G (S11ahl, 1965) or Adsorbosil - S (.Applied 
Science Labora'\ories, SU.ta College, Pa.). When Silica Gel G was used, the 
slurry was prepared ey mtxtng 30 grau With 6l'J ml ot water or 31 grams with 
51 ml ot water when Adsorbosil .. 5 was used. In either ca.se 1 distinct 
separations of lipid compone~s were obtained. 
Prseleaned 20 X 20 oni glass plat.es were ri.nsed nth aeetonf!t and w.lped 
dry. Arter shaking vigorous~ tor 90 secend13, the shi.rry -was poured into a 
"fixed-tr ... i.e'knen" spreader which was pulled across the glass plat>?ts to 
produce an even distribution or "11e Rlurry. The pla1es 11ere allowed to dry 
for 5 mi nu.te$, after w'liieh they were activated at an oven temperature of 105° C 
L 
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tor at leas'G l 1/2 hours prior to spotting. Af'1tE11" activation, the plates 
were removed trom the oven and allowed to cool. The lipids were applied to 
the plates with a 10 µL Hamilton qringe. five spots were applied for both 
the nuclear and mitochondrial tractions on one pl.attit with a total of 15 µ.L per 
spot. 'l'his represented a total or 75 µL per fraction. On a second plate, 
five spots nre applied tor both the ricroeomal and supernatant fractions. 
Fifteen µL per spot was applied tor microsomal lipids and 32 11L par spoi ror 
the superna\an\. Thestit quantities allowed oomnlete •er.>aration at the lipid 
components With no dit.ticulty in idcnti..:tication. 
The plates wre developed si.mul'kneously tor 25 minutes usin~ a mi.Xture 
or pe'troleum ether (85 parts), diethyl e'bher (15 parts) and glaci.a.l acetic 
acid (l part). In the ooncen~ntion •tudiee, J'FA and 'l'GrA were iden'Uf'ied 
atter spraying the pla 1ie With 2' 1 7•, diohlorotluoresoain and comparing 
s~s wi'\h unknown trac\ions under ulva-v1ole1; li~t.. The fraciions 
nre ou\lined and 1Jllnediate]¥ colleo\ed. In the radioisotope stu:lin, iden\1-
fioa'ti on 'RS made by placing the pla wa in iodine vapors wh1 ch wre allowed 
to fade before collecting FFA, TGFA and phoepholipida. The samples were 
collected from the plates w:tt;h a Cbromtlex Sample Recovery Tube (size 1-2 ml., 
Konte&J franklin Park, Illinois). The adaorben\ 'Plus lipid :trac'tion 1IU 
drawn on'&o the sintered glass partition by ncuum while being scraped from 
the pla'M. FFA and TGFA nre aeparated from the adsorbent by inverting the 
recovery tube and eluttng wiih 10 to l2 ml or chloroform. Phoapholipids wre 
eluted With 10 to l2 ml of anh7drous met.hanol. Samples :tor ooncen'Va\ion 
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studies were collected in 12 ml graduated screw-cap centrifuge tubes and 
sealed umer nitrogen until analyzed. In the radioisotope st11dies the 
sampl~s were eluted directly into acintilla.Uon vials. A 92 to 94% recovery 
was obta:i.ned by eluting w.iiih this :r.111iihod. 
(5) Elec'\ron microscow 
to determine the pur.lily ot the subcellular tractions 
obtained by ultraoentritugation, the nuclear, mitochondrial and microsomal 
pellets wore immediately placed into 3.12% glutaraldehyde buffered to pH 7.2 
a.nd f'ixed tor l 1/2 hours. Dur.ing this period, the pellets were out into 
very an.all pieces. Following fixation, the specimens were rinsed 3 times ~.n 
Millonig's p~cmphe.te butter, allowing one hour in the phosphate buffer per 
rinse. The specimens wre posWixed in bu.trerecl osmium tetro.xide, r~.nsed 
quickly in phosphate buffer and dehydrated with progresstve double rinses in 
35 1 501 70, 801 95 and 100 per cent alcohol. ..r'\fter 30 reinutes propylene 
oxide lfUS added, toll.owed by 1/2 propylene o.-nde and 1/2 Epon which mis 
allowed ·bo set for 2 hours. An equal volume of Epon was added and the 
specirn~ms allowed to set overr!ght.. The epon-propylene oxide Jdxture was 
discarded and tt1e specimenr.; a:mbedded in Epon in gelatin capsules and lncubaied 
at 60° C for 3 da;rs. 
1\:t"ter 1ncubaticm,. the speclmens vmre c·Jt into ribbons on 11 Porter-Blum 
Ultra-lficrotcme at thicknesses of approx5.mately 50-80 mµ. The specirnsns were 
placed on Forrvar-carbcn cc:itad grJds arn:i stained with uranyl acet~te for 
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l 1/2 hours a.rrl counter-stained for 5 minutes wl th lead citrate by the method 
of Reynolds (1963). 
The specinions weI'e observed and photographed w.i th the RCA Electron 
t'icroscope at va!"'i. o-v.s m.agnifieattons. 
B. CHEM""CAI .• DETHU!INATIONS 
In all the b:I.ochemlea.l analya:es, the reagents used were always of 
analytical grade. Detel"lld.nat1.cn of 11nknmm eonctmtrations were alwaye 
a.ocompar..ied b"J blanks ard sbn:iards which would nullity aey major or minor 
contamimtlon after calculalions. 'Blood sampl• tor lactate analysts were 
detproteinized cy placing 1 m.1 o.f woole blood in'io prechilled tl.bes contail'l.ing 
9 ml ot a 10% ftlu"ion ot trichloroacetic aeid. M''er ref'rigerated eentri-
f11ga'\ion1 '\he auperna,ant was analysed ft.tr lactate by the methoc! of Barker 
and Summerson (1941). The me~hod is based on the conversion of lactic acid 
to acetaldeeyde by \rea1mlen'ti With concentrated sulfuric acid, and the 
aoe'\alde~de dnermined by' its color ?"eactd.on w:t\h J>-hydroxy'diphe:nyl in the 
presence of cupric ions. Color as deiierml.ned on a Ba mah and Lomb, model 340 
eolorim.e1Hwr at a wavelerg\h ot S6S DJS.L. 
Blood samples tor pyruva1ie anal1&1s were dep:roWntzed by adding 7 ml 
of Whole blood to 7 ml ioe cold 10% 'richloroaoetic acid in polyethylene 
centrifuge 1n.i>es. Attar re.f'rigerated centr:ttugation1 the supermrtant was 
ana]¥zed far PJl'Uva'tie by the method of Friademann and Haugen (1943). In this 
method, pyruT.l.o acid ia converted \o pyruvic acid hydrazone by reaction wl th 
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214-dinitrophel\YllVdr&•ine and extrac1ied With toluene. The colored }\rdrazone 
derivative •s determined on a Bausch a rd Lomb colorimeter at a wavelength 
or ;20 ~. 
Oxygen oontent was de,ermined in blood samples collected anaerobically 
in chilled syringes by the microgaaometric method of Rough'\on and Scholarder 
(1943). The analysis is based on "1le change in volume of the gas bubble 
betore and atter trea\men\ with alkaline pyrogallol. 
Glucose wu determined on plas• separated by retrigera'Ged oenVU'uga'\ion 
trom blood sanplea oollec\ed in prechilled oen•r.t.f'uge tubes. The enzymatic 
anal.1'sis made use of Glucostat which involved the coupled enzyme reac1iions 
of gluc011e ox1dase and peroxidase. The reaction was stonped by the addition 
or 4 I. mi. Color, due to oxidized chromcgen, was proportional to glucose 
presence and was de'termined at a wawlengt.h of 400 - on '\he Bausch and Lomb 
Colorimeter. 
Plaama FFA concen'\ration WU de'\ermi.ned by use of the Dole and Meinertz 
(1960) metthod in the propranolol-a1;rial tacb1oardia and propranolol-norepine-
phrine experiments ard qy the Gcss and Lein (1967) ma1thod in the remaining 
experiments. Both •thods involved Uia ax\raction of ta'\ty acids in1to a 
hep'\ane phase w1 th subsequent titration. In \he Dole ard Memertz method, 
titra\ion 111 '\h dilute Na.OH is carried ou\ in a 11Wo phlse system with '\hymol 
blue in:licator. 'l'he advantage of the Goss and Lein method is 1ihat a sillgle 
phase sys-.em is used wi 'fih phenolphthalein indicator ard. 1ti 1irated wi:\h 
Na-ethoxide which gives a be1tter endpoint. Both methods bubble nitrogen 
through 1ihe systEl!lls as a means of m-t xing and prevent! ng co2 absorption. 
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FFA concentrations in the subcellular fractions were d.e1;ermined by 
directly titrating the elu"8.rrt; fran the thin-layer pla'\es with Na-ethoxida 
arrl phenolphthalein indicator. Two J ml samples were titrated after washing 
the chloroform elutant S tines with 0.02 N H:z."04. 
TGFA concentra1iions in the subcellular fractions were det8l'mined by 
titrating the fatty acid aoiet.T after saponi.fication in ethanolic KOH (Sheath, 
1965). Titration was carried out. as described abow. 
The concen,rationa or subs~ratea analysed wre de'\Ell."ained by con:paring 
concurrently run s'tiandard 'V'Bl.ues 111 th unknown values after subtracting the 
blank. 
In the radioiso'tope s't~iea1 the elutant which was collected directly-
in scintillation Vials, ._. napora'\ed to dryness by passing a ni'\rogen stream 
over the chloroform. or nsthanol which contained the lipid. The cocktail, 
containing 4g PPO am 50 mg FOPOP per liter, was tresbl.1' prepared With 
sulf'ur-free toluene and lO al •re added to each vial. The sainples were then 
counted on the Beekman 18-250 Scintillation Counter u1iilizing the automatic 
quench correction setting. Samples were counted for 100 min or to a preset 
error ot 0.3%. An efficiency curve was prepared to conwrt counts per minute 
(cpm) 1io disin'Mgrations per minu'be (dpm) by adding a known amount of benzoic 
acid-l-14c to 10 ml of cocktail and counting the sample at'\er successive 
additions of animal lecithin. This was toun:l to increase quenching by 
increasing the color of the a&mple to degrees which corresponded to that tound 
in the subcellular samples, primarily the phospholipid :tractions. 
C. PRFSEN'l',lTION OF DATA 
The arterial and venous blood concentrations of oxygen were expressed 
in cubic centimeters per 100 cc, glucose, lactate and pyruvate in milligrams 
per 100 co and FJ:i"'A in mi.croequivalents per liter. J(vocardial uptake or cac;ygen 
was expressed in cubic centinsters per 100g per minute,, carboeydra1ies in 
milligrams per lOOg per minute and F'FA in nd.croequivalents per lOOg per 
minute. 
Subcellular ooncen\rations ot FFA and TGF A were expressed in micro-
equi:valents ot suboellular lipid per 100 grams ot ven'\ricular muscle. 
Subcellular radioisotope ac1*1vities were expressed as dpm/g of lefi 
ventricular muscle. Sinoe there wre dirt"erences in radioisotope uptake in 
individual animals a.a 11911 as irdividual groups, the data was also expressed 
as per cent of to1ial su'bcellular aotiviV• In this wa;y proportional changes 
in FFA,, TGFA and PHOS activity could be shown irrespective of the 1total 
radioactivity removed by the heart. 
Statistical significance of :ne~bolic changes observed in these 
experiments was determined by Student's t teat for paired or unpaired samples. 
In the propranolol-a.trial t&cl\vCardia studies atatdstical analysis was carried 
out in 15 dogs after the data were paired in the same dog as f'ollows 1 levels 
of significanoe in one group were determined between the control per.i od and 
propranolol treatment, whereas in the second group, levels or significance 
were de1iermined betwen propranolol treatment and the period or tachycardia 
during ~-blockade. In the propranolol-norepinephrine experiments,, 
significance of metabolic differences in response to norepinephrine before 
arxi after administration of propranolol were statistically analyzed between 
10 paired control aoo norepinephrine infused dogs, and between 10 paired 
ccc1trol arrl norepinephrine inf·113ed dogs pretreated 1fi th propranolol. Levels 
of significance in the Di-e-AW' studies were determined in 4 dogs by com-
paring the average measured change during propranolol w:t th alterat:lons at 
51 10, 15 am 2S minv:tes atwr the admS.nistration of the dibutyryl 
derivative. In '\he subcellular studies• statistical significance was deter-
mined by tmpai.red analysis of oranges between the control and propranolol 
dogs am the control ani narepinephrine doga in both the concentration and 
radioisotope studies. 
A. A-V STUDIF.S 
CHAPT:m Ill 
EXPERIMENTAL RESUL'l'S 
l. Propranolol;:atr!al 'faohsardia 
In figure 3 the typical hemdymmic responses to atrial uchycardia 
are diagrammed tor one ot 19 dogs before and a:f'\er the administration of 
1 mg/Kg of propranolol. Tachycardia in the absence of beta blockade was 
accompanied by a decrease in femoral am let1i intraverrllricular pressures and a 
marked decline in dp/dt. Acba1nis\ra'iion of propranolol af\er tachycardia was 
terminated resulted in a reduo'\ion in bean rate and dp/dt, whereas arterial 
pressure increased slightly above con"1-ol. Subaequ11m\ to propranolol 1irea1i-
ment1 atrial tachycardia caused no measurable cha~e in dp/dt, although a 
decline was observed in both ta.moral and left 1ntraven,ricular pressures. In 
the recovery period, dp/dt was noted to decrease further, whereas femoral and 
lett intraven\rioular pressures and heart rate returned to levels observed 
a.f'ter treatment With propranolol. 
The increase in coronary blood flow llh.ich generally aceompardes a\crial 
\achycard1a (Wegria ll. !!.• 1966) was observed in two control dogs (table I). 
However, the admims,rat.ion ot propranolol prior to a1irlal tachycardia caused 
a signif'icant decrease in coronary blood flow (P < .05J fig. 4). A further 
decrease occurred when tachy'cartia was induced during the course ot be\a 
receptor blockade. 
l 
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The effects of propranolol on JIG"OC&rdial carbohydrate metabolism before 
and during atrial tachycardia are shown in .figure 4. Propranolol was 
observed to have no significant effect on the extraction ratio or uptake of 
glucose, lac1tate &rd pyruvate, whereas JIG"Oe&rdial o:xzygen consumption, measured 
in tour of 19 dogs, declined (table II). A1trial tac}\ycardia subsequent to 
beta blockade resulted in a slight increase in ax:ygen consumption accanpanied 
by an increase in the myocardial uptake of glucose (P < .05). The extraction 
ratios or both glucose (P < .os) ard lactate (P < .OS) were elevated during 
this period (fig. 4), whereas 1ihe ax'\raetion ratio and uptake of pyruvate 
were no1i changed signifieant]J'. 
In table I \he increase in the ext;raction ratio and myooard!al uptake 
of FFA du.ring a'rial 'tachycardia are given tor two dogs, before and af'\er 
propranolol 1irea1iutent. Significant charges were not observed tor carbohy'-
drates ard '\heretore, were not included in table IJ Maxwell n §! (l95S) also 
reported similar observa1ii ons, as wall as a reduction in D17ocardial. R. Q. 
during atrial taeb7cardia. The increase in FFA up\ake could have resulted 
f'ran beta receptor stimulation by stored norepinephrine released during 
elevations in heart rate (loch-Weser, 1965). As shown in figure 51 beiia 
adrenergic recep\or blockade caused a significant decrease in the ar1;erial 
level of FFA (P < .001) as well as a reduction in the myocardial extraction 
ratio (P < .02) am uptake (P < .001) or this substrate. Tachycardia follo-
wing propranolol caused a further but slight decline in the extraction ratio 
and uptake of FFA (P > .os). 
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FIGURE 3 
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fypical hemodynamic responses observed from one of fifteen dogs in femoral 
arterial blood pressure, left intraventricular press"tre, heart rate and rate 
of left ventricular systolic pressure development during atrial ta.chycard:f.a 
induced before and after the adnd.nistration of propranolol. 
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FIGURE 4 
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The effects ot aWial tachycardia on coronary blood now and myocardie.l 
carbo}Vdrate metabolism,· before and during the course of 13-adrenergic receptor 
blockade in fif,een dogs. 
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fifteen dogs subjected to atrtal taceycardia after treatD'S:r.t w:i. th the 
~locking drug, propra.nolol. 
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These results indicate tha\ alterations in rqocardial metabolism with 
propranolol are characterized by a significant reduction in J'FA uptake, 
accompanied by little or no change in the uptakeof glucose, lactate and 
pyruvate. When propranolol wae followed by atrial tachycardia, JDY"Ocardial 
carbolzydrate uptake increased, whereas FF.A uptake remained depressed. In 
tachycardia without propranolol \raatment, the extraction of FFA would 
norm.ally have increased above cor$rol. 
2. Propranolol-nor8»1neohtj.~e 
The intracoronary ad:m.inistration ot 0.02 µg/m::tn/Kg of norepinephrine 
did not significantly alter fem:>ral mean blood pressure, heart rate, coronary 
blood flow and coronary resistance from oontrol (table III). With a threshold 
dose of ncrepinephrine for inducing metaboUc changes in the left ventricle, 
a slight al though statisticall.y insignificant rise occurred in peak left 
intraventricular systolic -rressure, 'While dp/dt imreased in ffery dog 
(P < .01). Since the increase in external cardiac work caused by thts dose of 
norepi.nephrine may ba negligible (Gold !1 il• 1965), the rise in dp/dt 
appeared '\o be the only 1nd1eation or a.n al 'ierat1.on in tey"ocardial contrac-
tili ty. The inf'usion of norepinephrine follow:i.ng ~reoep\or blockade did not 
ellci t a rise in peak lett irentricular sys'\olic pressure or dp/dt. With the 
exception that a rise consistently occurred in coronary vascular rest.stance 
(table III), complete blockade of cardi.odynarnie responses to 13-adrenergic 
receptor stimulation was accompli.shed. 'l'he underlying mechanism for the 
incrvase may have involved norepinephrine stimulation of coronary alpha 
receptors, ltlich have recently been reported to cause coronary constriction 
(Bohr, 1967). 
Although it has generally been assumed that myocardial uptake o:r a 
metabolic substrate will deperd on its arterial concentration (Bing, 1965), 
norepinephrine infusion increased the uptake o:r glucose (P < 0.02) and lactate 
(P <0.01) in the absence of' a significant rise in arierial levels (fig. 6). 
No significant change in pyruvate was observed. 
Fig. 8 shows tha. t norepinephrine caused a significant rise in the uptake 
of FF'A (P < O.Ol) and on the basis that a linear relationship may also exist 
in the dog betften arterial P'F A levels and myocardial extraction ( Carlsiien 
!1 !!,1 1961), the reported experiments showed that the fJ-adrenergie agonist 
resul "tied in a 54% increase in myocardial uptake r:4 FF A With a concurrent 
imre.ase of only W in arterial level. S'Gatistical anaJ.¥sis shond that the 
mean difference between the per cent increase in arterial levels and myocardial 
uptake of Fr'A was significant (P < O.Ol). These results would suggest that 
norepinephrine facilitated the uptake of FFA by mechanisms other ttan its 
ef£eot on raising arterial levels. 
J'olloW'ing the administration of propranolol, norepinephrina infusion 
caused in the absence of a change in arterial levels, a decrease in the 
myocardial uptake of' lactate (P < 0.05) and pyruvate (P < 0.02, .fig. 7). 
However, the moat dramatic decline in substrate uptake was observed in FF A., 
where despite the use of norepinephrine, myocardial FFA uptake decreased by 
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terial levels, myocardial extraction ratio and uptake of plasma. tree fatty-
cida in 20 dcgs. In 10 or 20 dogs these pa.ra!:eters we:·e measured before and 
ter the intraooronaJJr administrc ti on of norepinaphri!:.e for 10 min, wh::.le in 
he rcrna:l.n.1.ng 10 r:ogs, these para.meters wore measured be.fora ani after the 
dministration of pro>rar.olcl pl11s intr-ucoronary norepinephr:i.ne for 10 min. 
inore than 90%, or from a.n average or l2.?ct:3 • .3 to 1.0±2.3 µEq (100 gm/min; 
p < 0.01). Although not statistically significant, a rise was found in the 
myocardial uptake of glucose trcm an average of 19.5 to 22.9 µM/100 g/min. 
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The decrease in uptake of lactate, pyruva'te and P'FA in the propranolol-treated 
dogs given NE was found to be in part due to the further reduction the NE 
causes in coronary blood flow. In 10 propranolol-treated dogs coronary flow 
averaged 64 ml/100 gm/min; f'ollOWing the administra'liion of intracoronary NE, 
coronary now further decreased to 54 ml/100 gm/min (P < 0.04). 
3. Dibutyry'l-o-AMP 
The effects of Di-c-AMP on JDTocardial J.i'F A metabolism sli>sequent 1;o 
j3-adrenergic bloclade are shown in fig. 9. Following the administration of 
propranolol, coronary sinus flow as wll as 11;.\T'ocardial FFA uptake, extraction 
ratio arrl arterial conoen'\ra 'Iii.on decreased. At s, 10 and 15 minutes at1ier the 
administration of Di-a-AMP, the ex1;raction ratio ar:d uptake steadily irereased 
above the propranolol level until a maximum response was reached at 15 minutes. 
This peak response corresponds closely to that reported by Posternak !.i !l 
(1962) tor the maximum hypergqcemic response to Di-c-AMP. These workers as 
nll as Beick !i fl. (1968) uaed a dose almost twice as great as that used in 
the present studt. es. It was in'Mres'\ing to fird tha't the increase in 
ntrooardial uptake and extraction ratio occurred With minor changes in coronary 
sinus flow or arterial levels. It appears that Di-c-AMP can directly reverse 
the JDTOe&rdial antilipclytic et.f'ect of propranolol by increasing the extraction 
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FIGURE 9 
Propraoololl Di-c-AMP (lmg/Kg) ( 2. 75m;v1<g) 
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The effects of Di-c-AMP on coronary sinus blood now, myocardial l"F A uptake, 
extraction ratio, and FFA concentrat:l.ons in the arterial and coronary sinus 
blood during ~drenergic receptor blockade in 4 dogs. Ten minutes af'ter 
propranolol admin1.strati_ on, blood samples and coronary sinus now were taken 
prior to Di-c-A.MP treatmen1i. 
of FFA as reflected by a reduced coronaey sinus concentration until a peak 
response was attaj_ned. W:l.thin 25 minutes after Di-c-AMP treatment, uptake 
and extraction ratio again declined. 
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Changes in myocardial FF A uptake in response to elevated FF A levels 
during an increase and decrease in 13-receptor activity are shown in Tables IV 
and V and figs. 10 and 11 for eight dogs. Con1irolled step increases in the 
arterial level, which can be referred. \o as the indeperdent variable, were 
compared with Jl\fOe&rdial uptake (dependent variable) to determine the linear 
regression by the least squares method. lfyocardial uptake of FF.A during 
propranolol and norepinephrine treatment was plotted against arterial levels 
after correcting the experimental coronary sinus flow to control and readjus-
ting the corresponding level in uptake (figs. 10 and ll). In 3 out of 4 dogs 
norepinephrine decreased the FFA threshold arrl elevated FFA uptake (JJ.45%) in 
proportion to the step elevations in arterial level tran control (Table IV and 
1
11 
fig. 10). On the other hand, propranolol caused a reduction in FFA uptake i\ 1 
{36.70%) in relation to control increases in arterial level and elevated the 
FFA threshold (Table V and fig. 11). Since hemodynamie parameters other than 
corom.ry flow were not conirolled, tm importance of these firr:lir.gs cannot be 
evaluated. However, it is interesting to note that, 1) there appears to be a 
threshold for FF A uptake by the heart, 2) ~eceptor activity may possibly 
alter this threshold and 3) FFA removal by the heart is increased linearly by 
elevating arterial levels in both norepinephrine and propranolol treated dogs. 
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Changes in Jl\fOCS.rdial P'FA. uptake in response to increasing FF A arlerial level.a 
before and during j3-adrenergic recep~r a't;imulation w::l. th norepinephrine. 
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B • SUBCELLULAit STUDIES 
Electron microscopy was employed to verify the purity of the subcellular 
fractions isolated. by differential ultra-cent:ritugation. This was determined 
in 3 sepirate experiments ard plates I to V are representative findings 
observed in 3 dogs. In plates I and II are shown the components of the 
nuclear fraction. A large portion of this fraction is made up of "heavy" 
mi toehondria With a lesser concent;m tion or nuclei. Sutherland !! !! (1962&) 
isolated "heavy• mitochon:lria in rat liver at 2200 g whereas, only 700 g were 
required in these stuiies on dog heart. The term heay:y mitochorrlria refers to 
the large size of this cell organelle when compared to light mitochondria in 
the mitochondrial fraction. This is illustrated in Plates II and III which 
were 1iaken at the same na.gn:if'ication. The nuclear fraction also contained a 
small &nount of muscle fibrils. 
The mitochondrial traction (Plates III a.rd IV) contained almost all 
"light" mitochondria With a small amount of lysosomes. There was little 
morphological similarity between these mi toehondria and those seen in slices 
of intact cardiac muscle. Hatefi and Lester (1958) an:l Ekholm ti, !1, (1968) 
reported similar observations. It is interesting however, that there appears 
'io be '\wo mo'!"phologically di.f'f erent types of mi toohondria present in both the 
nuclear and mitochondrial fractions. One type appears very osmiophilic and 
compact with very dense, tortuous cristae. The second type is less dense 
with less cristae. Green (1959) attributes these differences to the isolation 
procedure. However, Hatefi and Lester (1958) found not only morphological 
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eiridenee but also b:i.ochemica.1 evidance wh~.~ll dist5.ngu:! shed these two types or 
mi tooi::ondr:ia and sug09sted that they w0re functionally d:i.ff arer.t in ~· 
Sordahl !i ~ (1969) reported that th1.s morphological difference was related 
to the o:x::tdati ve stat,e of the mi toehondria at the time of fixation. F.kholm 
.tl ~ (1968) supports this view With studies on mitoehomrial morphology in 
which changes were found by the !.!!. vivo imuction. or anoxia. It is not known 
if these two mitochondrial types ha.ve different in si'tu functions, but th .. i.fl 
--
view is supporled by the fact that they are both isolated together in the same 
media ard respond differently. 
In Plate V is shown the composition of the microsomal pellet. It 
contains numerous glycogen granules, possible fragments of the endoplasmic 
reticulum ard numerous clear ar:d solid double membrane vacuoles. 
1. Concentration Studies 
Beta-a.drenergie receptor blcckade resulted in a significant 
reduction in FFA concentration (Fig. 12) in the nuclear (6.$9+2.02 to 2.31± 
1.60; P < .OS) 1 m1 tochondrial (ll.04:t3.90 to 1.85-t.94; P < .05), mi.crosanal 
(11.25+4.40 to 1.15+.38; p < .05) am supernatant (l18.l2i:29.30 to e.35•1.7?; 
P < .Ol) tractions. However, norepinephrine adminis'tiration caused no 
s1.gnifieant alt<lrations ln FF.A from control in artV of the four fractions. The 
concentration ot TGFA (Fig. 13) in response to ~-receptor blockade on the 
other hand, was sign:U'icantly increased in the mitochondrial (16.57±4.42 to 
33 .04±12.91; P < .os), microsomal (24.:n•5.50 to 42.51±15 .61; P < .o.;) and 
supernatant (52.76±16.59 to 191.42±80.57; P < .01) tractions With no 
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Alterations in subaellular 'l'GFA coooentrations in response to propranolol and 
norepinephri ne • 
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significant change observed in the nuclear fracticn. Norepinephrine infusion 
resulted in a reduction or TGFA in the nuclear (46.18*10.6? to 31.19+5.96), 
microsomal (U..57~5.50 to 17.43±2.01) arid supernatant (52.76'+16.59 to 26.80:1:' 
9.47) fractions but none of these changes were significant. 
In the A-V difference studies, norepinephrine infusion resulted in a 
significant increase in Ff''A uptake by the heart. However, FFA concentration 
in the suboellular fractions were unchanged from. control during norepinephrine 
administration. Thls probably indicates an irore&sed turnover ot FF.A, and 
not an increase in the pool size. The same conclusion ia suggested for TGFA 
since it has been shown that .fatty acids taken up by heart are initially 
incorporated into TGFA (Shipp !! !!• 1964). '1'he use o! Na-palmitate-1-l4c 
infusion during '4-receptor blockade ard s1iimulation was therefore important 
in t.he clarifica t1 on ot t.hese possibili 1ties. 
2. iadioisotoPi Studies 
The efficiency curve for the counting system employed is shown in 
Fig. 14. Since automatic quench correction was set to give maximum activity 
w.i.t.h the most qusnchsd sample, the efficiency curve is flat throughout the 
range a.t v1hich the &&mples were counted. This indicates that the quenching 
encountered was mai.nta.imd oonstant by the scintillation counter. Sirx:e the 
counting efficiency was maintained between 91.0 to 91.6%, the activ-lty of all 
the sanplas was corrected for an efficiency of 91.3% to determine dpm. 
p 
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The affects or propranolol and n0r!Jpinephrine en ?l\VOCa.rd1.al subcsllular 
d~strihuM.on of Na-palmi ta.te-l-14c are shown in f.5.gures 15 to 20. After 2 l/2 
m1nuteg, f3-arlrarie:rg:ic blockade eau~ed nc s1gn:tfic.;1nt alter<;it.'i.on from control 
::.n the distrlbution of FFA in any of tho fonr subcellular fract5.on.a when 
expressed as dpm/gram of left ventric~ lar muscle (fig. 1.5). Narepinephrine 
lowered the activity from control in all tour tractions but not signti'icantly. 
TGFA. activity (f'ig. 16) ircreased f'rom control during propranolcl in the 
nuclear (1148.1±201.3 to ':!792.0~6?.4; P > .05) 1 mitochondrial (1670.3+277.4 
to .3813.3±764.2; P < .05), microsomal (3952.6+?46.l to 718,.0tl241.2J P • .OS) 
and aupernatantt (3186.2±560 .. 2 to 6811.8±449.0; P < .001) tractions. During 
norepinephrlne :i.nf'usion, TGFA activ:tty inoreasod significantly in only the 
superratant f'ract:l.on (3186.2.+:560.2 to 6048.J'+ll?6.4; P < .05). Except for the 
decrease in the nuclear fract1 on during prouranolol 1ireatment (1000.7±165.? to 
56?.8:tl05.2; P < .05) 1 there were no significant alterations in phospholipid 
activity (fig. 17) with either 13-adrenergic receptor blockade or stimulation 
in any or the tour subcellular tract:tons. 
Although the amount of radioactivity incorpora1ied in the 3 experiment.al 
groups was not s1. gnificantly different (control: 58177 .S ±?134.2 dpm/gram; 
pro~;ranololt '74400.5~63.8, P > .OS; and noreptnephrine: 487LiJ..7:t50l4.61 
P > .05) individual vari.ation was great enough to warrant correction ot the 
results to per cent change of total activity for each experiment. The data 
tor 1ihese corrections are shown in tugures 18• 19 and 20. 
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The effects of pr~nol ol and norepinephrine on the subcellular incorporation 
of Na.-palmitate-1 , into nuclear (NUC), mitochottlrial (MIT), microsomal 
(MIC) and supermtant (SUP) FFA of cardiac muscle. 
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The e.ffeots of' propranolcl and noreptnephr:i.ne on the incorporation of labeled 
ym1m5_tat"3 ~ nto sub cellular P!IOS (NTJC-nuclear,. 1flIT""'1U'i. toch.ondrial, MIC-
microsomal, SUP-supernatant). 
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As sho'!lfn by the expression cf r,;si..clt? in dprr/gram, no significant cl'langas 
from control in FF.:l wero obaerved during ~-blockade or atiimulaticn when 
results ware axpi·essed as par cent of total activity (fig. 18) in the nu.~lear, 
.:nitochcndrial and microsomal fractions. Iiowaver 1 there was a signlf'icant 
roduc t:ton in FF A aoti v.I. ty in the superna itant fraction with propra.nolol 
(35.9+2.l tc 27.J~l.?; P < .Ol) and norepinephrino (35.9±2.l to 28.8±.6; 
"' < .Ol). The per cent incorporation into '.fGl.<"A (:f'ig. 19) was increased wi t.h 
fl-blockade j_n the mitochondrial (2.~+0.4 to 5.:2±0.8J P < .05) 1 micro-5om.al 
(6.6:t:0.9 to 9.6±.9; P < .o;) a.nd supernatan't (5.4!0.8 to 9.StO.S; ?< .Ol) 
fractions. Since the amount of label present in thd norepinephrine hearts was 
less than that observed in the other two groups, a significant. increase was 
now· observed for TGFA in the r.litochond:rial fraction (2.8t0.4 to 5.6t0.6; 
P < • 01). A more significant increase was also seen 1n supernatan' TGF A 
activity ( 5.4t0.8 to 12.2tl.8; P < .Ol). The reduction in supernatant 
phospholipid (fig. 20) with propranolol was the only significant dlange found 
after correction to per cent o! total aotivi"ty (l.9*.03 to l • .)t.15; P < O.Ol). 
The results of both the co:ncen1tration and radioisotope subcellular 
studies are qualitatively shown on the thin-layer sepa.rc.tion in figure 21., 
l'tti.ch roprener;ts rela.ti ve lipid conc~m1irations in the subcellular frac·~ions in 
response tc propranolol and norepir.ephrine. Figure 22 is an autoradiogn.ph 
of the same 1ih1n-layer plate. Lipids for the separation were taken from 3 
radioisotope exper:tments: l) control, 2) propra.nolol aid 3) norepinephrine. 
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The \bin layer separation was made by spotting 9 µ.L of the reduced lipids from 
the nuclear, mitochondrial and microsomal fractions in each experimental group 
ard 26 µ.L .f'rom each experlmemal group far the supernatant fraction. This was 
sepamted as described in the methods section. Figure 22 was prepe.red b:f 
placing a cheet of Kodak !:creen X-Ray film directly in contact w..tth the tM.n-
laye:!" pJa te and allowtng 4 days t0 e:;q.>oee 'before developing.. Si nee Na-
paJJ!'.i tate-l-l4c vms ~nf\1sed~ c~an,,.~e 1.:n F"'A are d:tfficnlt to 1'."lt~r:pret, 
however cha?".ges i~ TGFA wtth pr~ranolol are easi:t_y se<m ~.n both platefl_. 
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Thin-layer chromatographic separation or myocardial subcel.lular lipids during 
control ( C), propranolol (P) · arrl norepinephrine ( N). In ascending order are 
s hown POOS, cholesterol, FFA, TGFA and cholesterol esters • Indicator: iodine 
vapors. 
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FIGURE 22 
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Autoradiograph of figure 21 indicating Na-palmi tate-1-14c incorporation into 
myocardial subcellular lipids during control (C), prepranol.ol (P) a.nd 
norepinephrine (N). In ascending order are shown PHOS, cholesterol, FFA; 
TGFA and ch olesterol eaters. Exposure time: 4 days. 
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TABLE I 
CORONARY BLOOD FLOW AND MYOCARDIAL FREE FATTY ACID ME?ABOLISM 
IN TWO CONTROL DOGS SUBJECTED TO ATRIAL TACHYCARDIA, 
BEFCRE AND AFTl!It BETA-ADRENERGIC RECEPTOR BLOCKADE 
MYOCARDIAL 
CORONARY ARTffiIAL EXTRACTION MYOCARDIAL 
BLOOD FLOW LEVEL RATIO UPTAKE 
(ml/100 gm/min) (µEq/L) (%) (µEq/100 gm/min) 
Dos; 12 
Control 79.4 soo.o 28.S 11.3 
Tachycardia 83.2 567.2 57.l 27.0 
Pro:pranolol 60;.S 435.7 24.s 6.s 
Tachycardia 45.4 398.2 l?.7 3.2 
Dog lJ 
Con'\rol 77.8 635.9 38.3 18.9 
'fac}Vcardia 83.4 605.9 so.6 25.6 
Propranolol 75.0 445.s 28.2 9.4 
Tachy'cardia 66.? 420.0 31.9 8.9 
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TABLE II 
EFFECTS OF PROPRANOLOL ON MYOCAfi.D! AL OXYGEN 
UPTAKE BEFCRE AND DffiING ATRIAL TACHYCARDIA 
CORON.ARY 
HEART RATE A-V DIP'F BLOOD F:WW UPTAKE 
(beats/min) (ml/100 m1) {ml/100 (ml/100 
gm/min) gm/min) 
Exp. l 
Con\rol 170 l3.02 ?4.8 9.74 
Propranolol 132 U.03 49.0 s.40 
Tachycardia 190 10.41 56.8 5.91 
Exp. 2 
Comrol 148 l0.9S 47.a 5.23 
Propranolol 118 11.33 44.4 s.03 
Tachyoardia 175 12.93 43.3 s.s6 
Exp. 3 
Comrol 175 11.0? US.3 12.76 
Propranolol 125 11.64 79.0 9.20 
Tacb;rcardia 190 12.73 79.0 10.06 
Exp. 4 
Control 145 16.3 73.2 11.93 
Propranolol 130 17;.2 53.9 9.27 
Tachycardia 190 18.6 57.S 10.74 
11 
~ 
TABLE III 
ClARDIODDJAVIC RESPONSES BWCR E ( C) AND AFTER INTRACORONARY 
ADMINISTRA'l'ION OF 0.02 p.g;kg/min NOREPI~"EPffiINE (NE) 
Coronary 
Dog Femoral Mean Perfusion Caromr;r 
No. Blood Presstire Heart Rate Coronary Flow Pressure Resis\ance Peak LVSP LV dp/d'\ 
(mmHg) (beats/min) {ml/min/lOOgm) {J!llllfg) {mu Units) (:mmHg) {mmHg/sec) 
c NE c NE c NE c NE c NE c NE c NE 
2 90 92 195 200 76 75 96 97 l.26 1.29 ll? 118 3506 4342 
3 88 82 195 200 90 96 90 83 l.OO o.86 165 188 262.3 3494 
16 95 95 190 190 68 62 llO 106 1.61 l.?O 120 122 2447 2820 
18* ?6 89 155 157 57 70 79 89 l.38 1.27 95 118 2364 3725 
19 120 123 180 180 98 90 130 128 1.33 1.42 130 128 2200 23?0 
Z7 100 97 153 155 101 10,3 104 93 1.02 0.90 155 161 3090 3917 
Mean 95 96 178 180 82 83 102 99 1.26 1.24 ]JO l.39 2705 3445 
* 0 .05 µg/Ig/min of NE 
IN'l'RAOORONARY NOREPINEPHRINE (0.02 µg/Kg/min) .AFT:&1l 
VIOCARDliL BETA ADRENmGIC RECEPrOR BLlCKADE WITH dl-PROPRANOLOL {P) 
Dog 
No. p NE p NE p NE p NE p NE p NE p NE 
21 83 80 l40 133 53 49 89 96 1.67 1.95 116 114 1200 1373 
23 88 84 128 l20 61 52 99 £f"I 1.62 1.67 105 1Q3 1290 1201 
24 92 92 133 130 65 52 83 85 1.2? 1.63 135 133 2315 2089 
25 102 105 120 121 74 63 106 109 1.4.3 1.73 128 137 2043 207? 
26 102 88 130 123 56 43 108 93 1.92 2.16 108 93 2099 19.31 
Mean 93 90 130 125 62 52 97 94 1.58 1.82 llS ll6 1789 1734 
:j 
r-
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TABLE IV 
CHANGES IN MYOCARDIAL FFA UPTAKE IN RESPONSE TO INCREASING ARTERIAL FFA 
CONCENI'RATIONS DURIJlll CONI'ROL AND f3-ADREN1.J:RGIC RECEPTOR STIMULATION 
Corrected Coronary 
Exp. Arterial Levels Myocardial Uptake Myocardial Uptake Sinus Flow 
No. (~Eq/L) (&J.Eq/100 gm/min) (µ.F.q/100 gm/min) (ml/100 gm/min) 
Control Norepi. Con\rol Norepi. Control Norepi. Control Narepi. 
2 683.2 6.38.S 6.35 7.15 S.30± .89 6.92±1.49 28.6 59.2 
) 468.6 46.3 .. S 7.92 11.28 B.29± .43 l0.46tl.19 6.3.0 72.0 
4* 1059.5 885.3 16.70 S.36 17.62±1.68 9.75t1.46 93.6 68.2 
10 484.4 467.l s.66 ?.64 8.34* .59 8.27± .45 ?3.9 70.l 
mean 54;.4 52.3.2 7.,31± .59 S.SStl.09 
2 782•5 82.3.0 8 • .34 10.33 9.16± .89 12.48+1.49 36.l 49.0 
3 5.31.4 533.3 10.'79 12.99 10~37* .43 l2.78tl .. l9 63.7 74.7 
4 1194.6 1024.0 22•76 22.02 2l.88tl.68 19.SS:tl;,.46 93.6 69•9 
10 549.7 569.l 10.68 11.58 . 10.62* .59 U.17:t .45 70.9 64.2 
mean 621.2 641 .. 8 10.05± .59 12.14±1.09 
2 829.2 846.0 10.12 15.2.3 10.97± .89 13 • lB:tl .49 34.0 46.6 
3 577.l 597.1 12 • .38 12.92 11.88* .43 14.90±1.19 65.7 63.7 
4 1254.1 1088.0 26.00 24.06 2.3. 76 ±1.68 24.0Stl.46 S?.5 67.4 
10 685.7 61?.4 12.18 15.34 15 • .381: .59 12.54± .45 52.2 70.9 
mean 697.3 686.8 12.14* .59 13.54±1.09 
2 963.5 961 .. 2 l?.03 16.63 16.18t .89 16.66±1.49 79.6 40.8 
.3 628.6 ?18.8 13.14 19.96 13.59± .4) 18 .. 95±1.19 65.l 60.2 
4 1313.5 1264.0 23.49 35.81 25 .64 +.l .68 36.52+1.46 63.0 66.5 
10 1012.2 676.5 14.77 26.82 26.Sl+ .59 14.22+ .45 48.8 ?2.4 
mean 868.1 ?85.5 18.86t .59 16.61±1.09 
*Due to the large deviation in Dog #41 these values were not incluied in the 
calcu:la "ti ons • 
TABLE IV CONTINUED 
/j. Arterial 
Levels 
(µEq/L) 
/J Amount 
Coronar;y Sinus Dell vered 
Flow (average)* To Heart fj Uptake 
(ml/lOO gm/min) (µEq/100 gm/Jiiin) (µEq/100 gm/min) 
% Removed 
By Heart 
Control lorepi. Control Norepi. Control Narepi. Control Norepi. Control Norepi. 
75.8 
151.9 
322.7 
118.6 
16.3 .6 
262.3 
S6.S 62.0 4.28 ?.3S 2.74 3.59 64.01 48.84 56.5 62.0 8.58 10.l.4 4.s; 4.99 56.29 49.21 
;6.5 62.0 18.2) 16.26 11.SS 8.06 6.3.JS 49.;6 
average 61.25% 49.20% 
% Decrease in uptake due to corona:ey- blood flow increase: 
56.5 mlllOO gm/min x 61.25% • 62.0 xX 
x • 55.82% 
Actual % ex'iracted by heart was 49.20% 
55.82% - 49.20% • 6.62% inoreue in extraction 
due to norepinephrine 
correeted for 100% = 13.45% 
• •. A uptake ( norepine?hrine) .f. 
A uptake (norepinephrine) x .1345 :: true /!uptake (norepinephrine) 
True ~ up1r&ke (norepiner>hrine + 
ini t1al upt:J. ke ( ncrepinephri ne) 
or 8.55 µEq/100 gm/min 
' 
:: Coronary Sinus Flow corrected 
uptake 
Corrected 4 uptake (µEg/100 gm/min) 'Corrected Upt;ake (tf:EQ/l.00 g/min) 
t s.ss 
4.07 • 
• 12.62 
5.66 ' 
9.14 
I l4e2l 
' 
I 1?.69 
*Average coronary stnua flow obssrveC! daring increasing a.rtr:rial Fli'A levels in 
both control and norepinephr:i.ne infusion :for dogs 2, 3 and 10. 
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T .ti,JlI.E V 
CHANlES IN MYOCARDIAL FF A UPTAKE IN RES fONSE TO INCREASING AR'flm.IAL FF A 
CONCENI'HATIONS DURING CONI'ROL MID ~ADREN.ERGIC RECEPl'OR BLOCK.ADE 
Corrected Coron&FJ 
Exp. Arterial Levels Myocardia~take Myocard::.al~take Sinus Flow 
No. (µEq/L) (µEq/100 min) (µEq/100 min) (m.1/100 gm/min) 
Control Prop. Con\rol Prop •• Control Prop. Control Prop. 
5 56.3 .4 529.6 8.91 2.04 8.76• .17 1.98+.16 98.8 '72.4 
6 605.7 480.0 12.20 4.88 l2.'79:t: .84 5.55±.90 ?1.2 58.9 
7 520.8 474.; 6.65 ?.1.3 5.82:tl.20 ?.?O-t.a4 82.6 92.2 
9 394.4 422.5 4.58 2.12 s.06± .90 2.12:t.40'. 54.2 47.2 
mean 521.2 477.4 8.87* .64 3.22t.49 
5 676.l 670.4 12.10 7.36 11.92± .l? 7.54:1:.16 107.4 62.2 
6 720.0 645.5 17.23 15.64 lS;.?8± .84 l4•07:t:.90 7?.3 54.5 
7 655.0 551.7 12 • .32 13.02 13.70±1.20 ll.61±.84 79.1 S4.J 
9 569.0 60S.4 10.99 0.7? 9.53± .90 s.26-.:.40 48.8 41.0 
1mean 655.0 641.4 12.41± .64 9.96*.49 
s 766.2 676.l 14.68 8.0l 14.44± .17 7.??t.16 104.3 64.6 
i 6 765.? 766.9 16.68 19.72 16.97+ .84 20.32±.90 71 .. 2 51.8 'I 
r7 730.2 617.9 17.20 i.+.25 18.11±1.20 l4.96+.s4 84.3 ?3.S 
9 664.s 69S.6 u.os 10.67 11.98± .90 u.23+.40 4s.s 40.3 
im.ean 732.J 713.9 l/+.46± .64 13.llt.49 
5 Sll.3 715.5 15.90 9.41 15.70± .17 9.J2t.16 97.3 5?.6 
6 822.9 971.0 17.94 30.32 is.46t .s4 30.83±.90 66.8 52.7 
7 ?73.2 750.3 22.18 21.74 20.6.3 tl.20 21.66±.84 84.J 66.8 
9 6W7.3 845.l 12.64 16.J5 12.56± .90 16.cn+.40 50.3 40.J 
lmean 773.fl 843.9 15.57± .64 18.74±.49 
.1 Ar'fisrial 
Levels 
(µEq/L) 
Control Prop. 
13.3 .s 164.0 
211.0 a-36.5 
252 .. 6 366.0 
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TABLE V CONTINUED 
A Amount 
% Renoved Coronary Sinus Delivered 
Flow (average)* To Heart d Uptake By Heart 
(ml/100 gm/min) (µEq/J.OO gm/min) (µEQ/100 gm/min) 
Control Prop. Control Prop. Control Prop. Control Prop. 
74.7 53.6 9.99 8.79 3.S4 6.?4 35.43 76.67 
?4.4 53.6 15.76 12~68 s.s9 9.89 35.46 77.99 
74.7 53.6 lS.8? 19.62 6.60 15.52 35.29 79.10 
average 35.39 77.92 
$ increase in up\ake due to coronary blood flow decrease: 
74.7 ml/100 gm/m:in x 35.39~ = 53.6 cc/100 gm/minx X 
I • 49.3'2'/. 
Actual % e.x1;racted by heart wa.a 71.92% 
therefore 7?.92 - 49.32 • 28.60% decrease i.~ ex•raction 
due to propranolol 
corrected for 100 % • 3~.?<Jf, 
• •. ~uptake (prooranolol) -A uptake (propranolol) x .3670 = true ~ up~ke (propranolol) 
true /J uptake ... initial uptake c)~0ll?"&?l01ol) 
or 3 .22 µEq/100 gm/min = coronary sinus flow 
corrected uo'U.ke 
Corrected /J yptake Ci:~/100 P!IJ!!in) •cgrrected Upt§ie (ieEg/J.OO rm/min) 
' 
' 3.22 
4.71 t 
• 7.49 
6.26 
t 
t 9.48 
9.82 • 
l.3.04 
*Average coronary sinus flon observed during increasj ng ar"tierial FF A levels in 
both control ard propranolol treatment for dogs 51 6, ? and 9. 
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PLATE I 
Electronmi()rograph or ~·he nwocard al nuclear fraction (700g) i11dicating a. 
large amount of 11 heavy Ir mi tee hondria. wJ. th two nuol&i (x 6 ~ 750) • 
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PLl TE I I 
Elec1'ronmierograph of the ieyooardial nuclear f':mctton (?OOg) indicating the 
large pr oport i on of 11hea''Yu m.1.tooho:OOria present . Muscle fibrils can also 
be s een but ropresent only a s oo_l percentage of the total f ract:1.o ( :x 6 ,?50). 
PLATE 1 I 
Elaetronmicrogra.ph of th myooa . al i tochondrial tract. o (?OOOg) which 
shows the large amount or "light" .mitochondria reprasa ntat.ive or this traction. 
Very little contamination was found in th.i.s fraction (x 6,750). 
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.PLNI'E IV 
act:eonmi..erogra.ph of the myocardial rrdJwohondrial fractdon (7000g) showing t he 
orphologi cal di.ff erance in the mi 'b oi:-.h.ondria . One type is dark, very dense and 
osmiophilic, while the other type is less dalll3e and lighter in appearance 
(x 10;125) . 
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Electr nmicrcgraph of the myocardial microsoraal .f:ra.ct5.on (105 ,000g) s howing 
the largo amount of glyeogen granules a nd lar ger vacuoles representat.:i.ve of 
thi.s fraction. Vary little contam:i.mtion from t he mitochondrial fraction 
was observed (x 18, 600) . 
DISCUSSION 
Meiiabolic changes during P-&drenergic recept.or blockade occurred 
concomitantly with significant decreases in hear\ rate, dp/dt and coronary 
blood flow. The reduction in energy requireman\a of. the heart, indicated by 
a decline in myocardial performance, ma7 have been partly' responsible for the 
decrease in myocardial uptake of FFA. Hawver, a proportional reduction in 
glucose and lactate uptake did not occurJ their levels renained essentially 
unchanged rran control l.,.els. This would suggest. \hat. 11\Y'oe&rdial carbo}\ydrate 
utilization may have actual~ increased when considering tbs reduction in both 
P'FA extraction am cardiodynamics. A rise in carbohydrate utilization is 
supponed by the observation that the cardiac R. Q. was eleva'\ed w:t\h '3-
blockade (Mclema .!.i il• 1966) which would sugges1i that t.he reduction in energy 
metabolism was no1i as great as the proportional reduction in norocardial FFA 
consumption. Scbr&ier ard. lYerkl (1964) have also reponed an increase in the 
total R. Q. during fl-blockade. TM.a has been at1iribu'\ed to a decreased efflux 
of FFA from adipose tissue as nll as a reduct.ion in thsi.r intlux troa plasma 
(SchrMer and Bj8rntorp, 1964). 
The increase in rqocardial requirement tor energy-producing substrates, as 
reflected by an elevated oxygen consumption, d ur.lng atrial tachycardia in the 
propranolol-treated dog was fulfilled from a rise in the 11\Y'OC&rdial upt.k• of 
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carbohydrates. Free fa1ity acid uptake by the hear1i, which increased during 
control periods ot a1irial tachycardia, was markedly reduced afier propranolol 
treatment. These findings suggest that ~drenargic receptor blockade changes 
myocardial praferential uptake of FFA to carbo}\rdra"8s, a change which •ould 
support the role of the 13-receptor in con'\rolling nirocardial FFA uptake. 
It is interesting to add that these experiments could indicate 'that 
f'-receptor blockade theraw in patien1is w:l th diabewa aelli tus should be 
carefully evaluaiied since in \his disease,m;rocardial aetabolic requirements 
are satisfied primarily by extraction ot plasma l"FA (Goodale Q.11,1 1959). 
:Fur'\her support for the role ot P...,.dren .. gic reoe~or acti'Yi.t;y in regu-
lating JtYOC&rdial FFA uptake was seen by the infusion ot 0.02 ~g/Kg/ain of 
norepinephrine directly into the circumflex: artery of the hear1i. Al1ihough 
minimal changes in hemodynamic parameters were observed, FFA, glucose and 
lactate uptakes were increased aignifican\ly. Subsequent to propranolol 
1ireatment, Which lowers n'A uptake by the heart, norepineohrine infusion 
tailed to restore the m;yocardial uptake' of FFA. Conoomi tant 1li th this change, 
glucose un'bake was increased despite the reduction in coronary blood tlo•. 
These resulu suggest that an increase in kdrenergic receptor actirl'\y 
sUmula 'lies FFA incorpora:Uon by the mart which can be inhibited by the prior 
administration of propranolol. 
Although arier.tal levels ot glucose and lactai;e remained unchanged during 
each experimental procedure, signi.f'icam increases in their axtrac'tion by the 
heart occurred in atrial tachycardia, ar"er P-&drenergic receptor blocllade, and 
, I 
l 
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also during norepinephrine infusion prior to adminiotration ol propranolol. 
However, P-blockade resulted in a decrease in the arterial level of n A, an 
observation previously reported by Pilkington !!. !l,1 (1966). This reduction has 
been a'ttr1buted to inhibition of FFA mobilization trom adipose tissue, which 
could have caused an indirec'\ decrease in BJTOcardial FFA up'\ake. However, a 
direct relationship betwen uptake arrl anerial level (Bing, 1965) was not 
present, as shown by the decrease in the e:drac1;ion ratio, Which expresses the 
per cent extracted independent ot the ariierial level and i• inversely related. 
to the coronary blood now. '!'here.fore, the reduction in ar\erial PFA concen-
tration accompanied by a decrease in coronary blood flow should have increased 
the extraction ratio of FF A it no change in me'tiabolic requirements had occurred. 
Since the opposite effect was observed, the inhibitory action of propranolol 
on myocardial FFA uptake may have resulted from a direct blockade at the 
membrane level or on 1ntraoellular mechanisms involved in the \ransport ot 
this substrate. It is also possible \ha'\ the reduced extraction of PFA 111q be 
indirectly related to the loRred metabolic requirements occurring concomi-
tantly lllith decreased cardiodynamie parameters. The latter poasibility 
sugges'\s a generalized decrease in metabolic requirements ot the heart which 
should attect all substra'tes equally, however, glucose and lae'liate uptakes and 
extraction ratios were unchanged after Iii-blockade, indicating a specific effect 
on FFA. These findings were also suopor1ied by the findiJ¥:S at Satchell !! Ii 
(1968). Evidence for a direct effect is also shown when the metabolic require-
ments of the heart were elevated during ~blo(Jkade, FFA uptake remained 
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depressed, while carbohydrate extraction was significantly elevated. The 
independence of 11\YOcardial FFA uptake from arterial concentrations ard coronary 
~lood flow was also obserV'ed when arterial FF.A levels were increased during ~ 
blockade arrl ~-stimulation. With a constant coronary blood flow and arterial 
level, it was found that propranolol proportionately reduced the uptake of FF.A., 
whereas norapinaphrine increased t.he uptake or FFA by the hea.M. These studies 
also suggest that 13-e.drenergic recep'\or aeti vi \y may affect myocardial FF A 
uptake by altering the threshold for FF.A. enraction. Although the anerial 
concentration pl~ a role in determini.ig the availability ot a substrate tor 
extraction by the heart, it does not appear to be the major factor cont;rolling 
·llh.e quantity extracted. 
The action of propranolol in reducing myocardial FFA uptake may involve 
interrupting an active process required in FFA transport across the cardiac 
cell membram. However, sinoe FF A transport is thought 11io be a passi w process 
dependent upon int:l.!'&Cellular utilization (Evans, 1964), it is more like]J that 
1ihe ~locker is a~ting at the in1i:mcellular level. Potter (1967), using 
labeled propranolol, has shown trat although surtace receptors on atrial cells 
are present, they only occupy a small porli.on ot the cardiac cell surtace 
area. Potter has also demonstra1ied in subcellular fractionation of atrial 
cells equilibrated With the labeled drug, that most or tm antagonist in the 
tissue was bound to mitochondria, microsomal-sized particles and muscle 
fragments. Tmse results may indicate possible intracellular sites where 
propranolol could interfere With myocardial Ff' A utilization. 
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The exact mechanism by which ~drenergic receptor activity influenced 
myocardial. li"FA uptake was first suggested by the mechanisa of FFA mobilization 
from adipose tissue (See chapter l, section C-1). It was interesting to find 
that the substrates and enzymes involved in this mechanism were also fourd 
in cardiac muscle (see chapter 1, section C-2). These included the adef\Yl 
cyclase system, a hormone-sensitive lipase and a TGP'A pool which could act 
as a source for FFA. An increase in cardiac muscle TGFA concen1iration w.tth 
propranolol (Satchell !l U, 1968) was one ot the tirst repor1is to suggest 
the importance of this mechanism in myocardial FF A metabolism. Shipp !!.!, &l 
(1964) reported that FFA enracted by the heart are initially incorporated 
into triglycerides. Kreisberg (1966b) report.ed that epinephrine increased 
the utilisation o:t endogenous TGFA in the 1sola1;ed rat heart, While Gousios 
il !l. (1965) reported similar timings. Epinephrine and norepinephrine 
adminis'l;ered 1.n the intact anial (Gold !!. f1, 1965; Cowley !! 1!J 1969) 
increased myocard:i.al FFA up1'ake and o.xt.da tion. It was concluded from these 
studies that the ~drenergic receptor, which may represent adel\Yl cyclase 
activity (Robison 11 IL 1967), was regulating FFA uptake by '\he hear1i 
through increased degradation of endog~mus triglycerides. The changes found 
in the subcellular studies would tend to support this hypothesis. 
Propranolol, which decreased FFA uptake by '\he heart, also increased 
TGFA concentrations in mitochondrial, miorosomal and supernatant fractions 
with the greatest elevation occurring in the supernatant traction (250%). 
The increase in TGFA in these subcellular cornpartlli'nts was also conf'irmed. in 
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the rad~.oisotope sttHii.es. Concomitant Wi.th the increases in coneentraMon, a 
greater ineorporatton of Na-palm.itate-1-l4c was found in all subeellular 
fraet:t ons. These findings su~,gest that {:J-adrenerg:l.c blockade i.ncreases 
:tntracellular 'l'GFA concentrations by inhibiting the degradation rather than 
the synthesis of this substrate. !"rem the radioisotope studies, there also 
appears tc be a limit to wM.ch the concentration of TGFA can increase. For 
tt was found that the time lapse betwe~m the injection of propre.nolol to the 
infusion of the isotope determined the amount of radioactivity incorporated 
:l nto TOFA. If the t::tme bet•en administration of the two agents was prolongEtd, 
incorporation or activity was very low, sug~esting that synthesis and bloekade 
had approached 11. nw.ximum ard only a small amount of the label could then be 
iI'lCorporatnd. In pre11:minary experiments this time was found be\ween 7 1/2 
to 8 minutes after injection of the ~-blocker. TGFA activity in t.he miclear, 
mitochondrial, m:i.orosor.al am supernatant tract:! ons art.er 7 3/4 minutes was 
566, 672, 1215, and 1696 dpm/gram respectively as opposed to 11481 16701 
3952 and 31S6 i:n the control. If" the isotope was infused before aynthests 
and blockade ct TGFA degrs.da.t:i.on had reached a ma:x:tmum, an increase in 
activity would be found and this amount or t:! me was approximately 6 V2 
minutes or theoretically less. It was tor these reasons that isotope infusion 
was inittated 6 1/2 m1nutes art.er propranolol administration and not 10 
minutes as was observed in the eoncentra t~. on stud:tes. 
}.Torapinephr1.ne, which st:l.mulnted the myocarcB.a.l uptake or FFA, produced 
no significant changes tran control in TGFA cc~eentration ir the subcellular 
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fraet:i.or,.s. If TCF'A daeradation is important in the tra.neport of' FFA into the 
cel.1, the lac!<" of emn,i:;e :i.n TGFA eoncE'!nt:r.::ition may ha.ve renected an increased 
turnovar of FFA molecrnles through the TOFii. moiety. This was ecnfi:r.m.ed by 
the increased incorporat.i.on of activity in the subcellular components with 
the nest aign.U'ioant 1 ncr.,as!)s in the mi tochorrlrial and supernatant fractions. 
Sino!'i total tr:tglycar1.da concentration was unchan~ed during the 10 m:tnute 
i.nfus1.on cf. norepinepbr:1.ne, the tmrease in radioaotivi ty m:mld suggest that 
FF'A sxtraeted by tha hsart wre exchanged With tr.iglyceride-f'a\ty acids 
w.tthout cham;ing the pool size. Thie is also suppor\ed by the findings ot 
Schsuar a.nd Olson (1967) t:tn t the endogenous triglyceride glycerol pool :ta 
relattvely stable, arrl only llinimally exchangeable With newl.v incorporated 
exogenous triglyceride glycerol. The increase :ln 'l'GFA eonoentra:\ion w1. th 
13-bloekade would suggest that part at this pool is !)resent as par\ial glyoe-
rtcms wh..tch through tur'\her astari!toaM.on oonld elevat,e endogenons TOFA 
leval.s wtthont changing the total number or glycerol r1olacules. However, 
increases in 'l'OFA ccmcentrat1ons wtth l')l'opranolcl might also originate tran. 
the increase in gluoose u'::>take. Glucose, v1.a the mnbden-J,feyerhof pa1bway 11 
gives rise to L"'°""gl~rcarophosphate, the pncursor or 'l'GFA. Since only emall 
amounts ot glycerokina.sa are though'ti to be present in card:tao muscle (Wieland 
and Suyter, 1957), tree glycnrol ts probably not an important precursor at 
TGFA. Rmvever, recent evtdenoe s~gests tnat glycer.okinase concentrations in 
heart muscle may ba su:f'fic:f.ently high to play an 1.mportant role in tho direct 
convsrsion of glycerol to t-Qf-glycaronho~phate {Robin~on and Nmmholme, 196?). 
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~herefore, the complete degradation ot endogenous TGFA through the action of 
tri-a.nd monogly-ceride lipases (Biale ll !l• 1968) would result ln 3 FFA 
l!lolecules tar oxidation and a glycerol molecule for reqnthesis ot TGFA. 
The concentration ot FFA was markedly reduced in all subcellular fractions 
~uring 13-'blockade but radioactivity was reduced only in the supernatan"-
lrra.ction when corrected for to1ial ac1ivity. Since increases in arlerial levels 
elevated FFA rem'fal by the heart during proprano1ol 'ireaitlllent, i;he increase 
in arterial level resulting tram Na-pahdta'ie-l~ inf'uaion might account 
for the acUv:t.ty in the nuclear, m.:aoohondrial am mierosou.l tractions which 
was unchanged from comrol levels. HOW9Ver, a reduction in auperna1wln\ 
activity would suggest an inhibit.ion of FFA 1transpori across tba cell membrane. 
The results of 1ihe aubcellular studies iulicate 1iba'\ there are very 
~omplicated intracellular mechanism8 involved in lipid DBtabolism by "the heart. 
r.rhe different conoentra'lions and ac'iivitiea usocia\ed within each subcellular 
fraction suggest 111.ul.'tiple 111\racellular pools each tunc'M.oning at ditteren1i 
turncnrer rates. In adipoee tissue it has been foum tha:i lipolysia ard 
esterifioation proceed at different rates in different pans ot the cell 
(Dole, 1961}. The cha~es found in '\he subcellular fractions s1irongly eugges1; 
a similar situa1iion in 'ihe heart. Different intracellular canpartments ot 
IFFA and TOF.A found in these s1;udies have also been found in adipose tissue 
(lerpel et al, 1961 and Stein1 1962). However, in all of the subcellul.ar 
--
!fractions, the increase in TGFA concentration arxt activity occurs when FJ.i'A 
uptake ia either stimulated or depressed. 
, 
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Since the substrates ani enzymes necessary for FFA mobilization from 
adipose tissue are also present in cardiac muscle, the regulation of TGFA 
degradation represents a possible mechanism far the control ot FFA uptake by 
the heart. The locus of action of this mechanism (fig. Z3) in 1;he cytoplasm 
is supported by the observed cha~es occurr:t ~ pr:ina.r:i~ in the superna.1ian1i 
fr!!lCtion. The requirements for such a mechanism would be, l) 1;ha1; J'FA taken 
up b;r the heart are first incorporated into TGF.A before 'lheir intracellular 
utili1.ation ltlioh has been shOlfll by Shipp !! !l, (1964) and in adipose tissue 
(Shapiro !.! f!l, 1960) as well as in diaphragmatic muscle (Neptune !l ~, 1962), 
2) it requires tha adenyl cyclase system (SutheT'land ti !11 1962&J Murad !!. ~' 
1962c; arxl Robison !l l.L l96S), 3) an intracellular lipase that is responsive 
to changes tn c-AMP levels which has indirectly been shown by catecholamine 
stimulation (Bj&rn"°rp and Furman, 1962b and Mallov and Cerra, 1967) am 
directly by c-AMP and Di-e-AMP adm.in:l.s1iration (Kruger !1 i1J 1967 ard Okamo"° 
and Glaviano, 1970), and 4) a f'airly stable pool of cytoplasmic glycerol 
molecules Which may act as 1n1iracellular accep1iors for FFA molecules (Shenrer 
and Olson, 1967). 
Wi't;h propranolol administration, (fig. 23) it is thought that adeJVl 
cyclase activity is blocked, therefore reducing intracellular c-AKP levels 
Which in turn decreases lipase activity. this would result in an increase 
in TGFA conceniration and rad:toactivi:ty and a decrease in the intracellular 
FFA concentration concomitant With a reduced FFA uptake by the heart which 
was found in the present e:xperlments. This also suggests that synthesis of 
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FIGURE 23 
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Diagrammatic represnntat:,_on of a possible mechanir.m re~nlati:ng :rvoeard:ial 
FFA uptake. 
TGF A proc·Jeds independent of degradation. However, with norepinephrine, 
cyclase activity would be stimula tad, causing an increase in c-AMP levels 
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wl:lich would increase lipase activity. Thls would result in a breakdown of 
triglycerides With a concomitant increase in myocardial FFA uptake. The 
intracellular FFA concentration was not cha~ed W1 th norepinephrine and 
palml tate-l-l.4c incorporation was significantly decreased in the supernatant 
fraction. This differs With what is found in adipose tissue, since intracel-
l ular FF A levels imrease. However, the norepinephrine-stimula ted degra-
dation of TGFA in the myocardium is asf!ociated With an increased F:F'A oxidation 
(Challoner and Steinberg, l966a am b). This would exemplify the funotional 
difference or TGFA breakdown in adipose and cardiac tissue in that in the 
former, FFA are ma.de available tor increases in arterial levels whereas, in 
the latter, FFA are made available for myocardial intracellular utilization. 
Norepinephrine did not significantly decrease TGFA oonoentrations but did 
increase palmitate-l-14c incorporation into this substrate wh-1 ch indicated an 
increased turnover of FFA through the 'l'OFA moiety. This would also indicate 
that with norepinephrine the intracellular synthesis of Viglycerldes is 
approximately equal to their breakdown by the acti'f'e lipase. An increased 
FFA utiliza,;:,ion was sugges'l;ed by the reduction in superna\ant FFA activity 
although l4co2 production was not measured. 
The necessity for FFA incorporation into TllFA prior to oxidation is 
unclear. It would appear to be a wasteful energy process 1io activate fatty 
acids to the acyl form prior to their incorporation in TGFA and repeat the 
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process folloWing TOFA degradation for incorporation into the earnitine 
system (Fritz and Kaplan, 1960). However, it may be possible that trigly-
ceride-fatty aeids have a greater affinity for ~he carnitine system due to 
their cellular location or overalJ. structure while in the esterified form. 
Thls is onl,y a. hypothests whtoh must await !'uture clarif:tcation. 
Changes occurring in the nuclear, mitochondrial and microsomal rracti.ons 
in res-oonse to propranolrl and norepinephrine indicate that these structures 
may afao independently regulate FFA incorporation by a similar rooehan:tsm. 
It was found in the Di-c-A'MP st,1d:les that the d:tbutyryl derivative of 
e-Al~P wall! effective in reversing the proora.nolol inhibition of myocardial FFA 
uptake. Since c-AMP doeo not cross the cell membrane (Robison li il,J 1965), 
the dibutyryl derivatiYe of o-AMP, whieh :ts permeable (Bl•'~d'ie r !! I!.' 196P)_. 
was uaed. Although this is not absolute proof or tm proposed mechanism, it 
does suggest an independent control of FFi'A uptake even when arterial levels 
are low concomitant With reduced coronary bloed flow. In line With the 
proposed scheme (fig. 23), Di-e-AMP would cross the cell membrane and cau::ie 
the act1.vation of the triglyceride lipase. 'l'h:ls in turn would imrease TGFA 
breakdown and facilitate FFA transport unUl the dibutyryl derivative is 
inactivated by phosphodiesterase. It appears that the threshold for Jl"FA 
uptake was reduced since the arterial level was unchanged after Di-c-AMP 
adminis1ra tt on. 
Since the actual 'ltOVement of FF A acr~s the card:iac cell membrane is a 
passive process (Evans, 1964).t the increase or decrease in endogenous TGFA 
r 
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levels appear to maintain a coneentra ti.on gradient which either f'acili tat es or 
iP.Jiibits FWA transport. This is supported by the alteration in threshold 
determined in the arterial-level studies which in::reased with propranolol 
and decreased with norepinephrine. 
The conflicting reports of Gousios ~ !l (196.5) and Kreisberg {l966b) 
indieate that oatecholamims stimulate the oXidation of endogenous FFA through 
degradation ot TGFA. However, they could find no evidence ot an increased FFA 
uptake by lteasuring pal.mi tate-1-14c activity entering and leaving tho he~. 
Kreisberg recognizes this discrepancy :ln his work since he found an increase ot 
pahd.tate-1-l4c in myoeardial lipid as well as an inarease in 14co2 production 
Im.th epinephrt ne. Ho11ever, he believes it was due to his use r:-t an isola. ted 
heart wtth a reairculatory apparatus. Vftth epinephrine adminisiiration, 
endogenous TGF A were brr.ken do11rn am an exchange occurred between .fatty acids 
1der.ived f'rolll endogenous 'l'GFA an::i those in the riedi um. Since radioactivity· 
rwae used as an indjmtion of uptake, total FFA uptake could have increased 
ltrl.th n0 change in radi~etiVity due to the sinple exchange of labeled 
molecules. Oousios a§.! (1965) used a nonciroulatory isolated heart 
tpreparation am foum the ea.me results.. Hcwever, in their experiments, the 
preparation was perfused for 10 mnutes With the labeled palmitate-l..l4c 
solution before catecholamine administration. This would have allowed 
sufficient t:trie for palmitate to be incorporated into TGFA and when stimulated 
with eatechcla.m'1 nes 1 increased 'l'GFA degradation would result in label being 
released into the perfusing media and maek the increased uptake of FFA in the 
r 
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same manner that Kreisburg observed. These autr:ors did not measure tissue 
incorporation of the label ihieh would r.ava clarified their fir.dings. 
Since myocardial lipid metabolism seems to depend on sympathetic nerve 
a.ctivi ty (Jellinek §!. !11 1964), preVious me'ltabolic studies in the isolated 
heart concerned w1 th intennediate reactions of lipids or carbohydrates have 
given different results than a.ctuall:r occur 1n situ. Since the heart has & 
certain amount of stored catecholamines which can be released Yiith increased 
work loads or heart rate (Koch-Weser, 1965),, metabolism in the isclated heart 
w.bict. is devoid o! all mrve activity n;ay irrlicate a dard.na.nce ot lipid 
metabollsm. u.ntil tmse catecholamine stores are depleted and then convert to 
carbohydrate i.:.tilization. Metabolic respori.ses in isolated hearts which involved 
catecholamine ad?t.nistration probably represent mare closely the true 1!l situ 
effects ~s long as significant alterations in intracellular substrate 
concentraaions have not occurred. 
Physiologically, these f-:ndi q;s suggeet a very important role of the 
sympathetic nervous system in maintaining the integr-Jty at t.."ie heart. During 
periods of increased stress when s;ympatmtic outflow is hie1l, :tntracellular 
FFA are mde available to satisfy the elevated metabolic requirements. The 
studies of Rcbison !'!!?.. 11, (1965), Okamoto am Glaviano (19'70) and Kruger §! 11 
(1967) suggHst t:hat this intracellular increase in FFA may occur concurrently 
or even bcf orc the in:rease in contractility and phcsphorylase activation. 
aince lipoprotEiin lipase (Korn, 1955a) :ts abur:rlant ir1 heart muscle but not 
intracellularly (Olivecrona and Belfra.ge, 1965), availabillty of intracellular 
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1'"'IiA from TGF.~ degracta·t.ion may solely depend on 11h01·mone-sensitive 11 lipase 
ac·~ivation b;y the S,Ympathetic nervous system. If the nerves &l·a interrupted, 
the heart. would therefore respcnd much like a denarvated fat pad in that 
tissue lipid concentrations ·would iI:crease ma:z:kedly 1Ui t.h lipid turnover being 
severe:ly dopressed (Jellinek tl aJ.., 1S64). Clamping the vencus effluent 
f:rcTu the adranal glc:mas in a dog which had undergone a complete cardiac 
S)ln}JE;.thectariY results in d8&ti1 (Geis tl ~' 1970). This may i11 part arise 
from the inabilit;y of the hearii to utilize t:ndogenous lipids and therefore 
prevent the up·take of FF.A by t.h<; heart. Tb.is as well as other reports 
(Olson, 1949) confirm the primliry impor"G&nce of ruyoeh.rdial metabolic events 
in detenninirig the hemodynamic parameters within which the heart must perform. 
The control of ltheae metabolic events o,y the J3-ad,renergic receptor alsc 
suggests the. t tne sympathetic nervous systein pr cx:luctis biocheurdcal clla:rges 
which ultinate:IJ." .modifies cardiac mechanical perforroa.nce. 
r 
SUMMARY AND CONCLUSIONS 
A. Vyocardial uptakes and ex\raction ratios of glucose, lactate, pyruvate, 
' 
and FFA were determined in open-chest dogs beatore and during atrial tachy-
cardia, in a control period and after lJ-adrenergic receotor blockade. 1'.he same 
substrates were also measured during norepinephrine infusion ( .02 µg/Xg/min) 
before and after propranolol trea1mient (1 mg/Kg). 
l. The following changes lftJre founds 
a. A significant decrease in the up1take and enraction ratio of 
FF.A occurred during P..receptor blockade, whereas glucose, lactate and wruvate 
uptakes and extraction ratios did not change from control. 
b. In con1irol dogs, air:iil tachycardia caused a marked increase in 
'FF A up'tike with no significant chuge in '\he uptake of carbohydrates. 
o. In propranolol-treated dogs, a1irial 1iac}Vcardia increased the 
uptakes and extraction ratios of glucose and lactate, whereas FFA uptake 
decreased. 
d. Norepinephrine infusion increased m,rocardial extraction ratio 
and up1iake of glucose, lactate and FFA. 
e. After treatment with propranolol, norepinephrine infusion 
decreased lactate and pyruvate uptakes, while that of glucose remained 
unchanged. During the same period, FFA wre markedly decreased. 
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2. The resul1is ot these atudtes indica1ie that during {:S-&drenergic 
receptor blockade, the preferential utilization of' FFA by the heart is 
conver'\ed 1io carbohydrates. They also suggest a specific relationship of 
myocardial FF A uptake with f3-adrenergic receptor activity. 
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B. The etf'ec1i ot elevating arterial FFA levels on myocardial FFA uptake 
was determined in 2 groups ot open-ches'i dogs s l) bat ere am af''Ger propra-
nolol treatment (1 mg/lg) and 2) be.tcre and during the intracoronary infusion 
of norepinephrine (0.02 µg/ICg/mi.n). Arterial FFA levels were imreased by 4 
consecutive i nt'usions of' an albunti.n-Na-palmi "41ie solution during the control 
period and during either JJ-adrenergic receptor stimula ti1 on or blockade. 
l. The tollow.lng changes wre founds 
a. Norepinephrine produced a greater uptake per ir.crease in 
arterial level than during tblll control and the threshold f cr FF A uptake was 
decreased during i)-adrenergic receptor stimulation. 
b. Propranolol caused a lower uptake per ir.crease in arterial 
level than during the control and elevated the threshold for FFA uptake. 
c. lf;rocardia.l FFA uptake was d.e1ierm1ned during a con'firol pen od, 10 minutes 
after propranolol treatment (l mg/Kg) and 5, io. 15 and 25 minutes after the 
administration of 2.75 mg/Kg 0£ th• dibutyryl derivative of e-AMP subsequent 
"to '4>lockade. The results indicate that attar propranolol treatment, 
f 
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myocardial FFA uptake was decreased. However, the reduction in FF.A uptake 
during 13-bloekade was reversed Wi:bh Di-c-AMP pr~ressi vely until it peaked 
at 15 minutes. 
D. The subeellular concentration ot J'FA and 'l'OPA were Dl9&Sured in nuclear, 
mitochondrial, microsanal and supermtani .tractions of oardiac muscle in 3 
groups ot dogs i 1) conirol, 2) propranolol (1 mg/lg) and 3) n<repinephrine 
( 0.2 µg/Kg/min). 
l. The following alierations in concen,rations were founds 
a. Prcpranolol signii'ieant'.cy imreasad the trigl;yceride concen-
tration in the mitochondrial, microsanal and superna1iant tractions. The most 
pronounced change was toum in ihe sunernatant traction. ConcCld.\ant with 
these chang"'s' jl-bloekade significantly reduced FFA concentration in all 4 
tractions. 
b. Norepinephrine produced no significant alteration in FF.A or 
TGFA in the subcellular tractions. 
E. The incorporation or Na-pal.ntitate-1-14c into FFA, TG1A, and PHOS was 
dl!\ermined in subcellular fraetlons ot the heart in 3 groups ot dogs: 
1) control, 2) propranolol (1 mg/Kg) and 3) norepinephrine (0.2 µg/Kg/min). 
105 
l. The tolloWing changes were observed: 
a. Propranolol decreased significantly the incorporation of 
labeled palmi.tate into supernatant FFA, but did not change the activity from 
control in the nuclear, mitochondrial or microsomal tractions when corrected 
far per cent total activity. 
b. Propranolol increased incorporatton ot radioactivity in TGF.A 
of all 4 subcellular tractions and significantly in the m.t tochondrial, 
microsomal and supernatant tractions. 
c. Palmitate incorporation in PROS •s significantly reduced in 
the supernatant traction, but was uncha~ed in the remaining fractions in 
response to propranolol. 
d. Norepinephrine significantly reduced palm11iat;e incorporation 
into FF A in the supernatant. traction and did not change radioac'1v:t ty from 
control in the remaining tractions. 
e. Acfiivi ty in TGF.A were increased in all four tractions 111 th 
norepinephrine, whereas PHOS was unchanged from. oon'firol. 
F. The results of the subcellular studies indicated that ~-blockade 
depresses myocardial 1P'A uptake concomitant with an inhibition or TGFA 
degradation. Norepinephrine stimulation of FFA uptake by the heart;, however,, 
is accompanied by an imreased turnover of FF.A through the TGF.A moiety. 
f 
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The results r:4: these studies combined vTith the findings of others 
suggest that the m.e<ilanism at 11\YOoardial FF .A uptake is similar to that round 
in adipose tissue for the release of FFA and also sunriorts the simllari ty of 
adenyl cyclase activity and f3-edrenergic receptor activ:I.. ty. Stimulation ot 
adenyl cyclase by catecholami.nes in the heart results in the activation ot 
"hormone-sensitive" lipase whioh stimulates the degradation of TGFA. This 
makes available intracellular FFA tor ax:Uation as wol.l as a gradient for the 
passive transport of P'FA across the cell membrane. Administratior of 
propranolol, Which is thought to inhibit ade?\Yl cyclase or possibly the 
Ii-receptor, prevents the activation of "hormone-sens1 tive" lipase and causes 
an ioorease in TGFA levels. This prevents the transport ot exogenous FFA 
by possibly renDving the FFA intracellular "acceptor" site. 
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